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INTRODUCTION 
Bacteria possess the ability to rapidly adjust a number of diverse 
cellular processes in response to the availability of amino acids and 
other nutrients. Thus starving an amino acid auxotroph for its required 
amino acid results in the so-called stringent response consisting of the 
abrupt cessation of: stable RNA transcription (i.e., rUNA and tSNA); 
carbohydrate synthesis; phospholipid synthesis; lipid synthesis; phospho­
rylation of glycolytic intermediates; ^  novo nucleotide synthesis; trans­
port of nucleobases and nucleotides; and polyamine synthesis in addition 
to an increased rate of protein decay [see Cashel (1975) for review]. The 
bacterial cell emerges as an extremely efficient and complex organism 
capable of coordinating a network of interconnecting yet biochemically 
distinct pathways to the limitations of the media in which it must survive. 
In the words of Jonathan Gallant, "One begins to suspect that there are 
simpler control systems in the world than those which enable the humble 
bacterial cell to cope with an energy crisis." 
In 1969, Cashel and Gallant discovered two spots on autoradiograms 
from chromatograms of ^^PO^ labeled JE. coli extracts which they called 
magic spots I and II (Cashel and Gallant, 1969). These substances were 
synthesized by stringent (rel^) strains of coli in response to amino 
acid starvation. Isogenic relaxed (rel ) strains failed to induce the 
synthesis of these compounds and failed to give a stringent response upon 
amino acid starvation. Magic spots I and II have since been identified as 
guanosine 5'-diphosphate 3'-diphosphate (ppGpp) and guanosine 5'-triphos-
phate 3'-diphosphate (pppGpp), respectively (Cashel and Kalbacher, 1970; 
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Haseltine ^  al», 1972). The relA allele codes for stringent factor, a 
ribosome-associated protein which synthesizes ppGpp (Block and Haseltine, 
1974). 
Several lines of evidence implicate ppGpp as the pleiotypic mediator 
of the stringent response. For example, the accumulation of ppGpp occurs 
within seconds of imposing an amino acid deficiency. This precedes the 
inhibition of rRNA synthesis by about one minute (Cashel, 1969). Fiil 
et al. (1977) in an elegant set of experiments using modifier genes have 
proven that it is not the relA gene product itself which determines 
stringency, but rather it is the level of ppGpp. In addition, recent in 
vitro experiments have directly implicated ppGpp as the negative effector 
of the synthesis of rRNA (Reiness et al., 1975; Block, 1976), ribosomal 
proteins, EF-G, EF-Tu and RUA polymerase subunit a (Lindahl et al., 1976). 
The stringent response in coli has been the subject of numerous 
reviews; Edlin and Broda (1968); Ryan and Borek (1971); Cashel and 
Gallant (1974); Block and Haseltine (1974); Cashel (1975); and Gallant and 
Lazzarini (1976). The literature review that follows centers on three 
areas of ppGpp research: (1) the search for ppGpp and other unusual highly 
phosphorylated nucleotides in eukaryotes; (2) probing the regulation of 
ppGpp: the effects of tetracyclines and other antibiotics; and (3) the 
mechanism of action of ppGpp in the control of transcription. The purpose 
of this work is to shed light on these problems. Despite a voluminous 
amount of literature on ppGpp related research, these relatively new areas 
approach the heart of the matter. Namely, how does a small molecule 
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regulate a pleiotypic response, and do similar controls exist in higher 
organisms? 
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LITERAIUIŒ REVIEW 
The Search for ppGpp and Other Unusual Highly 
Phosphorylated Nucleotides in Eukaryotes 
Lower eukaryotes 
The evidence for ppGpp in lower eukaryotes has been mixed. When 
present, ppGpp is usually attributed to organelle synthesis, i.e., 
mitochondrial or chloroplasts, as opposed to cytoplasmic synthesis. Buckel 
and Bock (1973) have looked for ppGpp in amino acid auxotrophic strains of 
the mold Neurospora eras sa (leu ) and Ankistrodesmus braunii (arg ), a 
chlorccoccal green alga. In both strains RNA and protein synthesis are 
stringently coupled. The organisms were labeled with for various 
durations of amino acid starvation. Chromâtograms of the cell extracts 
revealed no label in the region where ppGpp migrates. These findings were 
not altered by increasing the specific activity of the increasing 
the duration of amino acid starvation or by employing two-dimensional 
chromatography. In addition, Alberghina et al. (1973) failed to detect 
ppGpp in Neurospora crassa grown on a poor carbon source, glycerol. In a 
similar study (McMahon and langstroth, 1972), Chlamydomonas reinhardi 
failed to synthesize ppGpp in response to amino acid starvation of an auxo­
trophic strain or by addition of the arginine analogue, canavanine, to a 
wild type strain. 
Klein (1974) has examined cultures of the cellular slime mold 
Dictyostelium discoideum for the presence of ppGpp. This organism, when 
in the amoebae phase of its life cycle, is induced to differentiate by 
stairvation. The differentiation is characterized by profound morphological 
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and biochemical changes (Jacobson and Lodish, 1975). Amoebae prelabeled 
with and growing exponentially in medium containing 100 Ug/ml 
penicillin and streptomycin were centrifuged and resuspended in a buffer 
of 2-N-morpholinoethanesulfonate (MES) in an attempt to induce ppGpp syn­
thesis. One- and two-dimensional chromatograms of extracts from these 
cells revealed a labeled compound which comigrated with authentic ppGpp. 
Also, the compound was quantitatively absorbed by charcoal indicating that 
it contains an aromatic ring and is therefore not a polyphosphate. The 
lability of the compound to phosphomonoesterase digestion and nitrous acid 
oxidation resembled that of bacterial ppGpp. Only starved cells synthe­
sized the compound. The characterization of the substance, however, was 
lacking in that no evidence was presented indicating the compound contained 
a guanine moiety. Also, other chromatographic systems should have been 
used. The compound may be an isomer of ppGpp or some other nucleoside 
polyphosphate. The addition of antibiotics rules out the possibility of 
bacterial contamination. It should be mentioned, however, that others 
have been unable to repeat these findings (Haseltine and Jacobson, as 
cited by Jacobson and Lodish, 1975). Also it is not known whether the 
substance was synthesized in mitochondria. 
In auxotrophic strains of Saccharomyces cerevisiae removal of a re­
quired amino acid halts the net synthesis of ENA after a brief lag (Roth 
and Dampier, 1972). In bacteria, chloramphenicol inhibits polypeptide 
elongation while allowing ENA synthesis to continue (Cashel, 1969). This 
is due to the fact that the A-sites on the ribosomes remain filled with 
charged-tRNA (the A-site must contain uncharged-tENA to induce ppGpp 
6 
synthesis). However, in yeast cycloheximide, also an inhibitor of poly­
peptide elongation, inhibits KNA synthesis after a brief lag (Roth and 
Dampier, 1972). Therefore although protein and RNA synthesis are coupled 
in yeast, there is reason to suspect that the mechanism of coupling is 
different from bacteria. 
Kudma and Edlin (1975) have searched for ppGpp in a strain of 
cerevisiae requiring arginine, leucine, and tryptophan. Cultures were 
labeled for several generations with Starvation was achieved by 
filtering the cells and resuspending in medium that lacked the required 
amino acids. The ribonucleoside triphosphate levels were examined by 
thin-layer chromatography. It was determined that these did not fluctuate 
significantly during amino acid starvation ruling out the possibility that 
the cessation of net KNA synthesis was due to RNA substrate limitation. 
Both growing and amino acid starved cells were analyzed for ppGpp synthesis 
using or (^**^0)-guanine but none was found. The authors conclude that 
ppGpp is not synthesized in yeast and that the mechanism of coupled RNA 
and protein synthesis is different from bacteria. 
In contrast to the previous report, Pao et al. (1977) claim to have 
found ppGpp in cerevisiae subjected to heat shock. Subjecting cells 
to 38°C for six minutes induced the synthesis of the compound. None was 
found at room temperature. That heat shock was required to elicit the 
synthesis of the compound may explain why Kudma and Edlin (1975) failed 
to detect it, although they didn't report the temperature at which their 
experiments were done. Pao al. (1977) reported an absence of bacterial 
contamination in their yeast cultures. The yeast compound was identified 
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as ppGpp by the following criteria; (1) comigration with authentic ppGpp 
in two separate two-dimensional chromatographic systems; (2) absorption to 
charcoal; (3) insènsitivity to periodate oxidation indicating the esteri-
fication of the 2' or 3' positions of the ribose moiety; (4) alkaline 
hydrolysis was at the same rate and produced the same breakdown products 
as ppGpp; (5) zinc activated pyrophosphatase yield the same breakdown 
products as ppGpp; (6) oxytetracycline which inhibits ppGpp synthesis in 
E^. coli also inhibits the synthesis of the yeast compound, although an 
extremely high concentration of the drug was used (2 mg/ml) ; and (7) 3-P-
glycerate phosphokinase, which phosphorylates ppGpp to pppGpp ^  vitro, 
also phosphorylated the yeast compound to a substance which comigrates 
with pppGpp. This evidence is the most complete characterization of ppGpp 
in any of the studies involving eixkaryotes. Provided the bacterial con­
tamination tests were adequate (these were: plating on MacConkey or rich 
nutrient agar plates), the synthesis of ppGpp in yeast subjected to heat 
shock is well substantiated. The authors attribute the ppGpp synthesis to 
mitochondria although they give no direct evidence for this. In JE. coli 
oxytetracycline inhibits the nonribosomal synthesis of ppGpp in addition 
to the ribosome-dependent reaction (see Results and Discussion). There­
fore, nothing can be concluded about the site of ppGpp synthesis in yeast. 
The synthesis of ppGpp in yeast is not stimulated by deacylated-tRNA 
since heat shock in a strain of yeast with a temperature sensitive isoleu-
cine-tRNA synthetase produced no more ppGpp than the parent wild type 
strain (Pao et al., 1977). Therefore the synthesis of ppGpp is induced by 
a different mechanism in yeast than in bacteria. Also, ppGpp must function 
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differently in yeast because shifting to 38®C, the temperature which 
stimulates ppGpp synthesis, increases rather than decreases the growth 
rate. Evidence concerning the possibility of mitochondrial ppGpp synthesis 
will be covered in a later section. 
Higher eukaryotes 
The stringent response in bacteria has been compared to the control 
of growth in higher organisms. Hershko et al. (1971) made a survey of the 
literature and concluded that in mammalian cells a diverse set of growth 
related biochemical pathways and processes seem to respond in a coordinate 
manner to environmental conditions which restrict growth. The authors 
called this regulatory program the pleiotypic response. Thus imposing 
serum starvation on Balb c/3T3 cells, a line of untransformed mouse fibro­
blasts, resulted in the inhibition of net RNA and protein synthesis, the 
stimulation of protein degradation and the inhibition of uptake of glucose 
and of certain nucleic acid precursors. 3T3 cells that were transformed 
with SV40 (SV3T3) showed a much weaker response to serum starvation. Com­
paring serum starved mammalian cells with amino acid starved bacteria is 
at the very least a simplistic approach. Stanners and Thompson (1974) 
have shown using a line of Chinese hamster ovary (CHO) cells temperature 
sensitive for leucyl-tRNA synthetase that there was no coupling of protein 
to KNA synthesis and normal protein degradation at the nonpermissive 
temperature (two parameters of the so-called pleiotypic response). Despite 
similar contradictions the possibility that ppGpp or a similar molecule 
might control growth in mammalian cells prompted several studies on the 
existence of such compounds in higher organisms. 
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Smulson (1970) was the first to publish on an attempt to detect ppGpp 
in eukaryotic cells. labeled HeLa cells were amino acid starved by 
incubating in the absence of amino acids or with the isoleucine analog, 
0-methylthreonine. Neither treatment induced detectable levels of ppGpp. 
Mamont et al. (1972) examined 3T3 cells subjected to various nutri­
tional down-shifts and were unable to detect any ppGpp synthesis. Cells 
were grown in for 15 h prior to starvation for serum alone or for 
amino acids plus serum. Formic acid extracts of these cells revealed no 
label in the region where ppGpp migrates on two-dimensional chromatograms. 
However, a mysterious spot which the authors referred to as "x" migrated 
near GTP. Spot x disappeared during serum starvation and reappeared upon 
addition of either serum or insulin (both of which antagonize the pleio-
typic response). No steps were taken to identify this substance nor have 
any confirming reports been published. The authors reported a limit of 
detection for ppGpp at 0.5% of the GTP level. 
Fan et al. (1973) examined a proline requiring line of CEO cells and 
were unable to detect any unusual nucleotides during normal growth or 
during amino acid or serum starvation. Similarly, Stanners and Thompson 
(1974) failed to detect any ppGpp synthesis in CHO cells temperature 
sensitive for leucyl-tRNA synthetase at the nonpermissive temperature. 
Also, Thammana e£ al. (1976) induced isoleucine starvation in synchronized 
3T3 cells using medium lacking the amino acid or with medium containing 
0-methylthreonine, an inhibitor of isoleucyl-tRNA synthetase. No ppGpp 
was detected regardless of the concentration of 0-methylthreonine or the 
length of labeling. Extract of cells from the beginning of the S 
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phase into G2 were analyzed. Primary cultures of mouse embryonic fibro­
blasts gave the same negative results. Their limit of detection for ppGpp 
was placed at 0.5-1% of the counts in GTP. 
In contrast to the preceding negative evidence, Rhaese (1975) has 
claimed to have found ppGpp and other nucleoside polyphosphates in various 
cell lines. However, the characterization of the compounds was based 
almost entirely on unpublished results which have yet to appear in the 
literature despite a two year period since the publication of the original 
article. The only autoradiograms presented in the article were of one-
dimensional chromatograms of extracts from labeled cells. It is 
well known that mammalian cells synthesize condensed inorganic phosphates 
(Griffin et al., 1965) which could account for Rhaese's spots. Others 
have examined the same cell lines used by Rhaese and have not found these 
compounds (Thmmmana et al., 1976; Stanners and Thompson, 1974; Fan et al., 
1973; Lazzarini, as cited by Pao et al., 1977). Clearly, the weight of the 
evidence is not in Rhaese's favor. This is especially evident in view of 
the fact that Rhaese discovered his compounds by merely labeling growing 
cells with ^ ^PO^, i.e., no special treatments were required to induce the 
spots. 
Although the evidence favors an absence of ppGpp in cultured mammalian 
cells the possibility of very low levels, possibly synthesized by mito­
chondria, has not been ruled out. 
Embryonic material has also been examined for ppGpp synthesis. Irr 
et al. (1974), using the ribosome-dependent ppGpp assay worked out for 
JE. coli ribosomes, claimed to have found that ribosomes from 10- and 11-day 
mouse embryos are capable of synthesizing ppGpp whereas ribosomes isolated 
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from older embryos or from adult mouse liver were inactive. The compound 
synthesized by mouse embryonic ribosomes comigrated with authentic ppGpp 
in three different chromatographic systems and was labeled using either 
(a-^^P) GTP or (^H) OTP. The amounts of ppGpp synthesis reported were 
significant, 37-69% of the rate found with JE. coli ribosomes. However, 
Silverman and Atherly (1977) have tried to repeat these experiments using 
the same mouse strain without success. In addition, the authors demon­
strated the absence of ppGpp in cultured embryos at various stages of 
development (see Results and Discussion). Irr has also been unable to 
repeat his experiments with mouse embryonic ribosomes (J. D. Irr, Genetics 
Unit, Massachusetts General Hospital, Boston, Massachusetts, personal 
communication, 1976). It appears very probable that the initial observa­
tion of Irr et al. (1974) was a result of bacterial ribosome contamination 
in their embryonic ribosome preparations. Similarly, in two recent re­
ports no ppGpp synthesis was detected ^  vivo in sea urchin eggs or embryos 
(Brandhorst and Fromson, 1976; Pirrone et al., 1976). In the former study, 
ribosomes isolated from sea urchin embryos failed to synthesize ppGpp in 
vitro. 
Mitochondria and chloroplasts 
Horvath et al. (1975) reported ppGpp and pppGpp synthesis in isolated 
rat liver mitochondria and pppGpp synthesis in isolated spinach chloro­
plasts, both incubated in the presence of ^*P0^. GDP greatly stimulated 
the production of these compounds. No other nucleoside diphosphate would 
substitute for GDP. However, addition of ADP plus GDP stimulated the 
synthesis of the compounds about twofold over that found with GDP alone. 
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Unfortunately, the characterization of these compounds was limited to one-
dimensional chromatography. These experiments have been repeated using 
Zea mays chloroplasts (see Results and Discussion). A small amount of 
label was found in the position where pppGpp migrates using one- and two-
dimensional chromatography. Sy e^ al. (1974) using ribosomes isolated from 
Chlamydomonas reinhardii demonstrated that neither the cytoplasmic nor the 
chloroplast ribosomes were capable of ppGpp synthesis. However, addition 
of E. coli stringent factor, the enzyme responsible for ppGpp synthesis, 
to the chloroplast ribosomes resulted in abundant ppGpp synthesis. No 
ppGpp synthesis was found using the cytoplasmic ribosomes plus the enzyme, 
Thiostrepton, which inhibits coli ribosome-dependent ppGpp synthesis 
also inhibited the chloroplast plus stringent factor assay. Combining 
coli ribosomal subunits with chloroplast subunits in the presence of 
stringent factor gave significant levels of ppGpp synthesis. The small 
cytoplasmic ribosomal subunit plus the large subunit of either the JE. coli 
or the chloroplast ribosomes resulted in a much smaller level of ppGpp 
synthesis. Combinations involving the large cytoplasmic subunit gave 
little if any ppGpp synthesis. In a similar study, Richter (1973) demon­
strated that yeast mitochondrial ribosomes could slightly stimulate ppGpp 
synthesis by coli stringent factor. Ribosomes isolated from yeast 
cytoplasm, reticulocyte or calf brain failed to stimulate stringent factor. 
These results point to the possibility that mitochondria and chloroplasts 
may contain stringent factor-like enzymes that are loosely associated with 
the ribosome and are thus lost during ribosome isolation. However, I have 
found no stimulation of ppGpp synthesis using mouse liver mitochondrial 
ribosomes with E. coli stringent factor (see Results and Discussion.) 
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Nonribosomal ppGpp synthesis in mitochondria is also a possibility. 
Bacillus brevis contains a ribosome-independent guanosine 5',3'-polyphos­
phate synthetase (Sy and Akers, 1976). 
Other unusual highly phosphorylated nucleotides 
Several reports of the presence of unusual nucleotides other than 
ppGpp in eukaryotes have appeared in the literature. Artemia salina (brine 
shrimp) encysted embryos are known to contain large quantities of ,P^— 
diguanosine 5^-tetraphosphate (Gp^G) and ,P^-diguanosine 5'-triphosphate 
(GpgG) (Warner and Finamore, 1965; Finamore and Warner, 1963). Gp^G and 
GpgG make up 45% and 7%, respectively, of the acid-soluble, ultraviolet 
absorbing material in Artemia eggs. These compounds are stored and syn­
thesized ±n the yolk platelets (Warner ^  al., 1972). Gp^G synthetase, 
the enzyme responsible for the synthesis of Gp^G has been isolated from 
Artemia embryo yolk platelets (Warner et al., 1974). The enzyme catalyzes 
the synthesis of one equivalent of Gp^G and PPi from two equivalents of 
GTP (Warner and Huang, 1974). Also, GDP and Gp^G are converted to Gp^G 
and GTP by the enzyme. There is a rapid decline in Gp^G levels during 
early development (Finamore and Clegg, 1969). It has been suggested that 
these compounds function by increasing the purine pool and by providing 
a source of energy through their breakdown (Warner and McClean, 1968). In 
this regard, Gp^G synthetase is capable of catalyzing the reverse reaction, 
i.e., the synthesis of two equivalents of GTP from one equivalent of Gp^G 
and PPi. In addition, enzymes that degrade Gp^G to GTP and GMP (dinucleo-
side-tetraphosphatases) have been isolated from rat liver and Artemia 
(Vallejo et al., 1976). Other dinucleoside tetraphosphates tested were 
also cleaved by the enzyme. 
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Diadenosine 5',5* * *-P^ ,P'*-tetraphosphate (Ap^A) has been found in 
various mammalian cell types (Rapaport and Zamecnik, 1976). It was re­
ported that Ap^A is synthesized in amounts varying inversely with the 
growth rate. Serum or amino acid starvation resulted in a 30 to 50-fold 
decrease in Ap^A. Inhibitors of protein or DNA synthesis caused even 
larger decreases in the Ap^A levels. The authors proposed that Ap^A may 
be a positive pleiotypic effector, stimulating growth when present and 
inhibiting growth by its absence. Ap^A was prestmied to be made by a back 
reaction of the first step in protein synthesis, namely amino acid adenyla-
tion; aa^'pA'Eaa^ + pppA —>A(5')pppp(5')A + aa^ + Eaa^. In order to 
ascertain the validity of assigning the term "pleiotypic activator" to 
Ap^A the following questions must be answered: (1) What are the kinetics 
of the Ap^A decrease following serum and amino acid starvation? In other 
words, do the changes in Ap^A levels precede or follow the parameters of 
the pleiotypic response?; (2) What are the molecular signals that regulate 
Ap^A synthesis and degradation?; and (3) What is the mechanism of action 
of Ap^A in controlling growth? Until these and other questions are re­
solved, the presence of Ap^A in mammalian cells will remain a curious 
observation. 
The presence of diguanosine nucleotides was reported in fungi (LeJohn 
et al., 1975) which were presumed to control transcription (McNaughton 
et al., 1975). However, the authors have since retracted their original 
characterization of these compounds which they refer to as HS-1, -2, and 
-3 (Goh and LeJohn, 1977). The authors now claim the HS compounds are 
complex dinucleotide structures of adenine and/or uracil. HS-3 was 
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presumed to coordinate salvage and ^  novo nucleotide biosynthetic path­
ways in mammalian cells. 
A charcoal extractable, acid-soluble inhibitor of ribosomal ENA syn­
thesis has been reported in Xenopus embryos (Shiokawa and Yamana, 1975; 
Yamana and Shiokawa, 1975). This substance has not yet been characterized 
but may be a nucleotide. 
In addition, eukaryotic mMAs possess a capped 5'-end of the general 
structure: m'CpppX™ . . . (Shatkin, 1976). This structure will promote 
initiation complex formation with ribosomes for most eukaryotic mKNAs and 
may be involved in the control of translation. 
In addition to the above mentioned studies with eukaryotes, several 
novel nucleotides have been reported in prokaryotes as well. Gallant 
et al. (1976) have discovered a compound they call phantom spot character­
ized as "a form of GTP with a modification of the imidazole portion of the 
purine ring." Phantom spot decreases rapidly upon energy source down­
shift. The authors suggest the compound is a positive effector of cellular 
processes including RNA accumulation. The compound is apparently adjusted 
to the overall rate of phosphorylation in the cell. 
Adenosine 3'(2*)-diphosphate 5'-diphosphate, ppApp, adenosine 3'(2*)-
diphosphate 5'-triphosphate, pppApp, and other compounds have been found 
in Bacillus subtilis and are believed to be synthesized in response to 
conditions promoting sporulation (Rhaese et al., 1976; Rhaese and 
Groscurth, 1974; Rhaese et al., 1972). Thus ribosomes isolated from 
vegetative B. subtilis cells synthesized ppGpp and pppGpp whereas ribosomes 
isolated from sporulating cells synthesized ppApp and pppApp (Rhaese and 
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Groscurth, 1974), 
Also, Oki et al. (1976) have reported an enzyme from strains of 
Actinomycetes, purine nucleotide pyrophosphotransferase, capable of syn­
thesizing purine nucleotide 3'-diphosphates, e.g., pApp, ppApp, pppApp, 
pGpp, ppGpp, pppGpp and ppplpp. Out of 825 strains of bacteria and fungi 
tested, only 5 strains, all Actinomycetes, synthesized the enzyme. The 
enzyme is apparently excreted from the cells during growth. Its function 
is unknown at the present time. 
Loewen (1976) has reported the presence of two novel nucleotides, 
DSI and DSII, in coli and other bacteria. These compounds inhibit in 
vitro KNA synthesis by coli RNA polymerase (Klassen et al., 1976). DSI 
was reported to consist of coenzyme A and glutathione; DSII is a coenzyme 
A dimer with two equivalents of glutamic acid. 
Finally, Rapaport et al. (1975) have demonstrated that ApppGpp, 
AppppGp, and Ap^A can be formed ^  vitro as by-products of amino acid 
activation. 
Summary of the literature concerning the search for ppGpp in eukaryotes 
Table 1 is a summary of the published evidence on the search for 
ppGpp in eukaryotes. In almost every instance where ppGpp was found there 
is evidence to the contrary. Unfortunately definitive statements can not 
be made at this time. However, certain conclusions can be drawn from the 
available data. These are: (1) although lower eukaryotes do not synthe­
size ppGpp in response to starvation (with the possible exception of 
Dictyostelium), for at least yeast, ppGpp synthesis can be induced by heat 
shock; (2) mammalian cells in culture probably do not synthesize ppGpp, at 
Table 1. The search for ppGpp In eukaryotes* 
Cell type or organism Condition(s) Reference 
Neurospora crassa (leu ) 
Anklstrodesmus braunll (arg ) 
Neurospora crassa 
Chlamydomonas relnhardl 
(arg" or arg^ 
Saccharomyces cerevislae 
(arg-, leu", trp") 
HeLa cells 
Mouse fibroblast line, 3T3 
Chinese hamster ovary cells, 
CHO (pro") 
Chinese hamster ovary cells, 
CHO (leuStS) 
Embryonic mouse fibroblasts 
and mouse fibroblast line 
3T3 
Mouse embryos (various stages) 
Sea urchin eggs and embryos 
Negative evidence 
Leucine starvation 
Arginlne starvation 
Nutrient dovm-shift 
Arginlne starvation or canava-
nine 
Amino acid starvation 
Amino acid withdrawal or 
0-methyl threonine 
Serum and amino acid starva­
tion 
Serum and amino acid starva­
tion 
Shifting to 39.5°C 
Isoleucine starvation and 
with 0-methyl threonine 
In vitro ribosome-dependent 
assays, in vivo assays with 
starvation 
*2pO%-labeling in vivo 
Buckel and Bock (1973) 
Buckel and Bock (1973) 
Alberghina et (1973) 
McMahon and Langstroth (1972) 
Kudrna and Edlin (1975) 
Smulson (1970) 
Mamont ^  al. (1972) 
Fan et al. (1973) 
Stanners and Thompson (1974) 
Thammana et al. (1976) 
Silverman and Atherly (1977) 
Brandhorst and Fromson (1976); 
and Plrrone et al. (1976) 
Positive evidence 
Dictyostelium discoideum 
amoebae 
Saccharomyces cerevisiae 
Chinese hamster ovary cells, 
CHO 
Baby hamster kidney cells, BHK 
Mouse embryos (10- and 11-day) 
Rat liver mitochondria 
Spinach chloroplasts 
Starvation 
Heat shock 
Labeling growing cells with 
Labeling growing cells with 
In vitro ribosome-dependent 
assay 
Incubating with ^^P0\ + GDP 
Incubating with ^^P0% + GDP 
Klein (1974) 
Pao et (1977) 
Rhaese (1975) 
Rhaese (1975) 
Irr et al. (1974) 
Horvâth et al» (1975) 
Horvâth et al, (1975) 
^Only published evidence is included. 
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least not in detectable quantities (i.e., less than about 50-100 nano­
molar); (3) mammalian embryos probably don't synthesize detectable quanti­
ties of ppGpp; and (4) mitochondria and chloroplast synthesis of ppGpp and 
pppGpp has not been ruled out; however, if a ppGpp synthesizing enzyme is 
present it probably is either loosely associated with the ribosomes or not 
associated with the ribosomes at all. The last three points are largely 
substantiated by the work to be presented (see Results and Discussion). 
Probing the Regulation of ppGpp; The Effects of 
Tetracyclines and Other Antibiotics 
The requirement for the ribosome-dependent synthesis of ppGpp and 
pppGpp are the following: stringent factor, both ribosomal subunits, mRNA., 
an uncharged-tRNA specific for the codon at the A-site, ATP and GDP or GTP 
(Block and Haseltine, 1974). In addition, Zabos et al. (1976) have 
reported stringent factor-independent synthesis of pppGpp in E, coli post-
ribosomal supernatant. Ribosome-independent synthesis of ppGpp has also 
been reported in Bacillus brevis (Sy and Akers, 1976) and Actinomycetes 
(Oki et al., 1976). This review will only be concerned with the effects 
of antibiotics on the ribosome-dependent stringent factor synthesis of 
guanosine polyphosphates. 
Various antibiotics which interfere with one or more of the steps 
involved in ppGpp and pppGpp synthesis and degradation have been useful 
in helping to elucidate the regulation of these unusual nucleotides. The 
literature concerning these antibiotics is reviewed below with emphasis on 
the tetracyclines. This is because tetracycline is the only antibiotic 
known which directly inhibits ppGpp synthesis (see Results and Discussion). 
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In addition, tetracycline has other intriguing properties affecting ppGpp 
decay and transcription. 
Antibiotics affecting ppGpp synthesis 
Inhibiting protein synthesis through amino acid starvation in coli 
rel"*" results in the cessation of the synthesis of stable species of RNA 
(Gallant and Lazzarini, 1976). This is due to the accumulation of un-
charged-tRNA in the A-sites which triggers ppGpp synthesis. However, 
direct inhibition of protein synthesis with chloramphenicol causes an un­
coupling of the stringent control of RNA synthesis (Neidhardt and Fraenkel, 
1961). Kurland and Maal^e (1962) have demonstrated that chloramphenicol 
relieves the dependence of ENA synthesis on an external supply of amino 
acids in auxotrophic strains cultured in medium lacking a required amino 
acid. This was interpreted as evidence that inhibition of protein synthe­
sis causes an increase in the amino acid pools by permitting proteolysis 
with little consumption of the recycled amino acids. This high internal 
concentration of amino acids would then generate charged-tKNAs which in 
turn would inhibit ppGpp synthesis. This has in fact been observed 
(Cashel, 1969; Lund and Kjeldgaard, 1972). This effect is not specific 
for chloramphenicol; other inhibitors of protein synthesis bring about a 
rapid decline in ppGpp levels (Lund and Kjeldgaard, 1972). Addition of 
chloramphenicol, tetracycline, fusidic acid or puromycin to amino acid 
starved rel^ cells resulted in a rapid decay of ppGpp (a half-life of 
about 30 seconds) and a resumption of RNA accumulation after about 2 
minutes. 
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The inhibition of ppGpp synthesis is direct only for tetracycline. 
The other protein synthesis inhibitors operate indirectly by sparing amino 
acids or by interfering with tRNA binding to the A-sites. In contrast to 
the situation ^  vivo, the ^  vitro ribosome dependent assay for ppGpp 
synthesis is inhibited only by tetracycline and thiostrepton (Block and 
Haseltine, 1974). Both of these drugs inhibit binding of tKNA to the 
A-site (Levin, 1970; Cundliffe, 1971). However, tetracycline will inhibit 
the ribosome-independent stringent factor assay as well (see Results and 
Discussion). This indicates that the effect of tetracycline on ppGpp 
synthesis is direct and does not depend on interference at the A-site. On 
the other hand, thiostrepton does not directly inhibit stringent factor 
(Sy et al., 1973). Fusidic acid has also been reported to inhibit ribo-
some-dependent in vitro ppGpp synthesis (Cochran and Byrne, 1974). 
However, this may be due to the detergent effect of the drug at high con­
centrations (Block and Haseltine, 1974). Concentrations of fusidic acid 
that inhibit polyphenylalanine synthesis ^  vitro by 90% have no effect on 
ppGpp synthesis (J. Bodley and M. Cashel, as cited by Cashel, 1975). 
Kaplan et al. (1973), by measuring levels of charged-tKNA in vivo, 
have demonstrated the amino acid sparing effect of inhibitors of protein 
synthesis and the uniqueness of tetracycline in directly inhibiting ppGpp 
synthesis. The authors used mutant strains of coli leaky and nonleaky 
^ ts for amino acylation of tKNAs. In two nonleaky mutants, 5F2 rel (gluS ) 
"I" ts 
and 10B6 rel (valS ), it was demonstrated that the only protein synthesis 
inhibitor which caused an uncoupling of RNA synthesis and an inhibition of 
ppGpp synthesis at the nonpermissive temperature was tetracycline. In 
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contrast, NP29 rel (valS ), a leaky mutant, RM synthesis is uncoupled 
by chloramphenicol in addition to tetracycline. As mentioned previously, 
inhibitors of protein synthesis will result in amino acid sparing. These 
recycled amino acids will charge their respective tRMs. In the case of 
the leaky mutant synthetase, a trickle of charging will occur at the non-
permissive temperature resulting in an accumulation of the charged-tRNA 
in the presence of chloramphenicol and an inhibition of ppGpp synthesis 
with a stimulation of RNA synthesis. However, in the nonleaky mutants no 
trickle-charging can occur, therefore the level of uncharged-tRNA remains 
effectively high with chloramphenicol, ppGpp synthesis is maintained and 
RNA accumulation is inhibited. Muto et al. (1975) reported that chloram­
phenicol inhibited ppGpp synthesis in temperature restricted nonleaky 
strain 10B6 rel^. However, they did their experiment at 40*C whereas 
Kaplan ^  al. (1973) did theirs at 42°C. 10B6 rel^ may be slightly leaky 
at 40*C but not at 42°C. 
Others have presented evidence indicating that the effect of chlor­
amphenicol on ppGpp synthesis may not depend on levels of charged-tKNA. 
Gallant et a2. (1972) have shown that basal levels of ppGpp are reduced 
in a rel strain by chloramphenicol. Since rel cells do not induce ppGpp 
synthesis in response to uncharged-tRNA these results are at variance with 
those of Kaplan et al. (1973). Also, Glazier and Schlessinger (1974) have 
measured levels of charged-tRNA in a mutant temperature sensitive for EFTs. 
At the nonpermissive temperature, EFTu cannot be recycled by EFTs; instead 
it accumulates as EFTu-GDP. Therefore charged-tRNA-EFTu-GTP cannot be 
formed allowing even a small percentage of uncharged-tRM to effectively 
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compete for the A-site thereby resulting in ppGpp synthesis. Under these 
conditions, it was found that chloramphenicol did not significantly alter 
the fraction of charged-tRNA. in the cell and yet ppGpp synthesis was in­
hibited. It may be that there are two mechanisms by which chloramphenicol 
inhibits ppGpp synthesis, one involving an elevation of levels of charged-
tRNA. and another unknown route. 
In addition to inhibiting the synthesis of protein and ppGpp, tetra­
cycline also interferes with ppGpp decay (to be discussed later) and ENA. 
synthesis. Atherly (1974a) reported that 500 )ig/ml tetracycline specifi­
cally and totally inhibited the synthesis of rKNA while allowing the syn­
thesis of unstable species of RNA to continue. He reported that at low 
concentrations of tetracycline (about 50 Hg/ml) RNA synthesis was stimu­
lated, but at high concentrations (250 to 500 vg/ml) RNA synthesis was 
inhibited. The former can be accounted for by the inhibition of ppGpp 
synthesis by the drug. Several trivial explanations for the inhibitory 
effect of tetracycline on RNA synthesis were examined and ruled out, e.g., 
magnesium chelation, increased ppGpp synthesis, isotope exclusion and 
inhibition of nucleoside triphosphate synthesis. As will be discussed 
later, the levels of nucleoside triphosphates reported in the paper may be 
erroneous. It was later found that 500 yg/ml tetracycline will signifi­
cantly inhibit the synthesis of pyrimidine ribonucleoside triphosphates 
(see Conclusions and Summary). Atherly (1974a) postulated that tetra­
cycline acts at sites where ppGpp acts. This may only be partially true, 
however, because ppGpp depresses the synthesis of purine and pyrimidine 
triphosphates (Cashel and Gallant, 1968; Gallant et al., 1971), whereas 
24 
tetracycline only inhibits the synthesis of pyrimidine triphosphates. The 
effect of the rel^ phenotype on nucleotide synthesis vivo has been 
disputed by others (Edlin and Stent, 1969). The hypothesis that tetra­
cyclines mimic some effects of ppGpp is discussed in more detail later 
(see Conclusions and Summary). 
The effect of tetracycline on rKNA. synthesis has been verified by 
others (Glazier and Schlessinger, 1974). They demonstrated that in a 
mutant strain with a temperature sensitive EFTs, 300 Ug/ml tetracycline 
inhibits ppGpp synthesis and rKNA. synthesis at the nonpermissive tempera­
ture. 
In addition, 5a,6-anhydrotetracycline, a derivative of tetracycline 
(Figure 9), has been discovered which will completely inhibit RNA. synthesis 
and ppGpp synthesis at concentrations as low as 20 ng/ml (see Results and 
Discussion). 
Trimethoprim has been used to study the role of N-formylmethionyl-
tRNA.^®' in the synthesis of ppGpp. This compound inhibits dihydrofolate 
reductase and thus inhibits the synthesis of purines, thymidine, glycine, 
and methionine as well as the formylation of methionyl-tRNA.^^^ (Arnold and 
Ogilvie, 1977). Trimethoprim was found to affect RNA. and ppGpp synthesis 
+ — differently in rel and rel strains of jE. coli supplemented with amino 
acids and nucleobases (Khan and Yamazaki, 1972). In a rel"*" strain tri­
methoprim caused the stimulation of ppGpp synthesis and the cessation of 
RNA accumulation. In contrast, the rel strain did not accumulate ppGpp 
and only gradually inhibited RNA synthesis. This was interpreted as 
implicating unformylated methionyl-tRNA^ in the stimulation of ppGpp 
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synthesis. However, more recently Arnold and Ogilvie (1977) have shown 
that the effect of trimethoprim on ppGpp synthesis was probably the result 
of methionine depletion. They demonstrated that the addition of methionine 
to trimethoprim treated cells caused the level of methionyl-tRNA.^ to rise 
while unformylated methionyl-tRNA^^^ remained low. This caused a rapid 
depression in ppGpp levels. Therefore, imformylated methionyl-tRNA.^ 
does not induce ppGpp synthesis. 
Rifampicin results in the disappearance of ppGpp from amino acid 
starved rel"^ strains (Lund and Kjeldgaard, 1972). This is probably due to 
a combination of two effects. The first is the disappearance of mRNA to 
function in the ribosome-dependent synthesis of ppGpp. Secondly, the 
resulting inhibition of protein synthesis will cause amino acid sparing to 
occur (Cashel, 1975). 
Antibiotics affecting ppGpp degradation 
Most of the reports concerning effects of antibiotics on ppGpp decay 
are related to the discovery of the spoT gene. Laffler and Gallant (1974) 
were the first to recognize the existence of the spoT allele. îfiitants in 
this gene were initially characterized as lacking pppGpp [recently it has 
been shown that pppGpp accumulates transiently after amino acid starvation 
(Fiil et al., 1977)] and having higher than normal levels of ppGpp and 
an increased stability of ppGpp. The authors mapped the spoT gene at 
about 72 min and determined using merodiploids that spoT^ is dominant over 
spoT . They hypothesized that the spoT gene product was involved in con­
verting ppGpp to pppGpp. However, recently it has been determined from an 
isotope flow experiment that ^H-guanine is incorporated into GTP, then 
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into pppGpp, and finally into ppGpp (Fiil et al., 1977). Therefore, the 
reverse is true, i.e., pppGpp decays to ppGpp. Various models for the 
function of the spoT gene product have been proposed (Fiil et al., 1977; 
Chaloner-Larson and Yamazaki, 1976). All of the models incorporate the 
spoT gene product as a principal enzyme in the degradation of ppGpp. The 
half-life for ppGpp increases from about 20 seconds to as much as 10 
minutes in spoT**" and spoT strains, respectively (Fiil et al., 1977). 
The spoT phenotype is closely resembled in cells undergoing a carbon 
source down-shift transition (De Boer et al., 1976) indicating a possible 
link between the function of the spoT gene product and the availability of 
energy in the cell. 
Stamminger and Lazzarini (1974) investigated the effect of oxytetra­
cycline on ppGpp decay. They found that high concentrations of the drug 
(250 yg/ml) inhibited ppGpp decay in spoT strains but not in nearly iso­
genic SPOT"*" cells. Although 50 ]ig/ml oxytetracycline inhibited protein 
synthesis by 97%, this concentration of the drug had little effect on 
ppGpp degradation in spoT cells. This indicates a lack of correlation 
between the rate of protein synthesis and ppGpp decay. The authors 
suggested that the inhibition of the two processes are independent. The 
failure of oxytetracycline to inhibit ppGpp decay in spoT"*" strains was 
explained by suggesting that there are two routes for ppGpp decay, a fast 
and a slow one. The former would be identical to the spoT gene product, 
the latter would be present in spoT**" and spoT strains and would be in­
hibited by 250 Vg/ml oxytetracycline. Therefore, oxytetracycline would 
appear to have no effect on ppGpp decay in a spoT^ strain because the fast 
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pathway would be operating. However, the results could also be accounted 
for if there were only one pathway for ppGpp decay, that of the spoT gene 
product. In spoT strains the mutant enzyme would degrade ppGpp at a 
greatly reduced rate and would also become sensitive to oxytetracycline. 
The effects of tetracycline on ppGpp decay in cold-shocked cells of 
spoT^ and spoT strains have been compared (Raue and Cashel, 1975). Cells 
were made permeable to small molecules by simultaneous temperature and 
osmotic shock. ppGpp degradation could be measured by first labeling with 
and then adding unlabeled phosphate to dilute out the specific 
activity of newly synthesized ppGpp to an insignificant level. By follow­
ing the decay of ppGpp in this manner it was determined that the rate of 
ppGpp degradation was stimulated by amino acid availability or by the 
availability of energy-rich compounds. 
Using this technique the authors found that 500 yg/ml of oxytetra-
cycline or tetracycline almost completely inhibited the degradation of 
PPGpp in spoT strains while having no effect in spoT**" strains. These 
results are in agreement with those of Stamminger aad Lazzarini (1974). 
In addition, Raue and Cashel (1975) found another apparent difference in 
spoT mutants. EGTA (ethyleneglycol-bis-(B-aminoethyl ether)-N,N*-tetra-
acetic acid) which binds divalent cations but not magnesium was found to 
inhibit amino acid-dependent stimulation of ppGpp decay in a spoT strain 
but not in a spoT^ strain. This inhibition of decay was reversed by 
manganese. The authors conclude that the slow decay of ppGpp found in 
spoT strains requires manganese and is inhibited by tetracycline. 
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5a,6-Anhydrotetracycline will also inhibit ppGpp decay in whole cells 
of a spoT strain but at a concentration of only 20 yg/ml (see Results and 
Discussion). This inhibition of ppGpp decay was curiously reversed at 
higher concentrations of the drug and also with manganese in accord with 
the findings of Raue and Cashel (1975). 
In addition to tetracyclines, at least two other drugs which inter­
fere with ppGpp degradation have been studied; these are: the quinone, 
6-amino-7-chloro-5,8-dioxoquinoline, and the morphone analog, levallorphan. 
Ogilvie (1976) has reported that a quinone that inhibits leucyl-tRNA. 
synthetase caused a spoT phenotype to occur. He proposes that the amino-
acyl-tKNA synthetases provide a route for the decay of ppGpp. This 
assumption is supported by the discovery that lysyl-AMP and ppGpp are con­
verted to ApppGpp and lysine by lysyl-tRM synthetase (Rapaport ^  al., 
1975). 
Raue and Gruber (1974) have reported that levallorphan increases the 
level of ppGpp in spoT and spoT^ strains. No pppGpp was induced in either 
strain; in fact, addition of levallorphan to amino acid starved spoT**" 
cells caused the disappearance of pppGpp. It was determined that the drug 
increased the decay time of ppGpp about 10-fold in both spoT and spoT 
strains. The authors conclude that the main effect of levallorphan is to 
inhibit the degradation pathway of ppGpp. The site(s) of action of 
levallorphan is unknown. 
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The Mechanism of Action of ppGpp in 
the Control of Transcription 
Because ppGpp is a highly charged nucleotide it is impermeable to 
whole cells. Studies requiring the addition of exogenous ppGpp therefore 
require that special measures be taken. These experiments run the gamut 
from relatively mild alterations of the cell, namely permeabilization, to 
studies with purified RNA polymerase and DNA. In order to ascertain 
whether ppGpp is a direct effector of transcription, the nucleotide is 
added to the various systems with the subsequent analysis of the tran­
scripts or gene products. 
In exponentially growing cells rRNA comprises about 40% of the in­
stantaneous rate of total RNA synthesis even though the rRNA genes comprise 
just 0.4% of the genome of E, coli (Gallant and Lazzarini, 1976). During 
the stringent response, rRNA transcription is reduced ten- to twentyfold 
while mRNA is only inhibited about twofold. One of the basic problems in 
trying to detect a preferential restriction of rRNA synthesis with ppGpp 
in vitro is that purified transcribing apparatus frequently makes much less 
than 40% rRNA. There is also a large experimental error associated with 
RNA-DNA hybridizations used to analyze the transcripts. With these impor­
tant limitations in mind, the literature on the mechanism of action of 
ppGpp in the control of transcription is critically reviewed. 
Cashel (1970) measured the effect of ppGpp on transcription with 
purified components, i.e., E. coli RNA polymerase and DNA. It was deter­
mined that overall RNA synthesis was inhibited about 40% by concentrations 
of ppGpp present in whole cells during a stringent response. Isomers of 
ppGpp were not inhibitory. It was found that transcripts starting with 
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guanine were inhibited to a much greater extent than transcripts having 
an adenine at the 5' end. No attempt was made to determine if there was 
preferential inhibition of rRNA synthesis. However, since nascent tran­
scripts of rRNA. begin with adenine (Steitz et al., 1976), it is unlikely 
that ppGpp would inhibit initiation of rRNA synthesis by acting as an 
analog of GTP. More recently, Cashel et al. (1976) reported that d(I-C) 
directed synthesis of r(G-C) was inhibited by ppGpp whereas d(A-T) directed 
synthesis of r(A-U) was not affected. It was determined using rifampicin 
that ppGpp inhibited initiation of transcription of d(I-C) and not elonga­
tion. The effect was specific for ppGpp as several GTP analogs did not 
inhibit. These experiments indicate that ppGpp can inhibit certain initia­
tions ^  vitro. However, the relevance of highly purified systems to the 
situation ^  vivo remains to be determined. 
Lazzarini and Johnson (1973) used cold-shocked coli to study the 
effect of ppGpp on RNA synthesis. By injecting a concentrated suspension 
of cells into buffer at 0°C, the cell became permeable to nucleoside tri­
phosphates and to ppGpp. Although the rate of UNA synthesis in this system 
was only about 30% of that in whole cells and the ability to synthesize 
protein was almost totally lost, the cells do retain the ability to syn­
thesize 30-40% rRNA. Total RNA synthesis was inhibited by about 50% by 
ppGpp; however, there was no preferential restriction of rRNA synthesis. 
The authors conclude that ppGpp does not directly and specifically inhibit 
rRNA. synthesis in permeable cells. It was suggested that ppGpp may acti­
vate a negative repressor of rRNA synthesis which could be lost or in­
activated by the cold-shock treatment. In this regard, Smeaton and Elliot 
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(1967) reported that cold-shock treatment of IB. subtills caused the re­
lease of a protein inhibitor of rihonuclease with a molecular weight of 
about 12,000. 
Atherly (1974b) has developed a permeabilization procedure in which 
cell viability is reduced by less than 10% and RNA. and protein synthesis 
are maintained at near normal rates. The treatment consists of rapidly 
injecting a concentrated suspension of washed cells in 50 mM Tris-HCl, 
pH 7.4, 10 jM MgClg at room temperature into a stirring solution of IM 
Tris, 10 mM mgCl^ at 2-5°C. The simultaneous osmotic-temperature shock 
makes the cells permeable to nucleotides. The permeabilized cells synthe­
sized about 30% rRM. In agreement with Lazzarini and Johnson (1973) it 
was found that neither induction of uncharged-tRNA. or addition of ppGpp 
changed the percentage of rKNA synthesized. Overall levels of RM synthe­
sis were inhibited about 30% by ppGpp. 
Kimura (1976) examined various permeabilization procedures for their 
effect on the stringent control of RNA. Using the procedure of Atherly 
(1974b) it was reported that RNA synthesis was stringently coupled to 
protein synthesis during induction of uncharged-tRNA. However, during the 
first five-to-ten minutes after the cold-shock there was no coupling of 
RNA to protein synthesis in a stringent strain. Atherly (1974b) labeled 
during the first 10 minutes after the cold-shock. These findings may be 
explained by assuming that the cells are capable of partially repairing 
their membrane by 10 minutes. During this period a relaxed phenotype is 
observed in a stringent strain perhaps because an effector of rRNA synthe­
sis is inactivated or leaked from the cells by the treatment. An 
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alternative explanation is that Rimura used slightly different, perhaps 
milder, conditions than Atherly. Kimura obtained similar results with 
toluene-treated cells. However when the toluene-treated cells were incu­
bated with LiCl no stringency was found even after 30 minutes incubation. 
LiCl resulted in an enhanced disruption of the cells as evidence by a 
leakage of protein. Similarly, no stringency was found in spheroplasts 
incubated in hypotonic medium. The author concluded that the stringent 
control mechanism is dependent on a functional cell membrane and that 
cold-shock and toluene treatment are less disruptive to the cell membrane 
than toluene^LiCl or hypotonic treatment of spheroplasts. 
Various cell-free systems have been developed to study the effects of 
ppGpp on transcription. Purified KNA. polymerase and DNA. synthesize only 
2-to-lO percent rRNA. Murooka and Lazzarini (1973) described the isolation 
of a DNA-protein complex from coli which was capable of sustaining 
newly initiated RNA s]mthesis containing 30% rRNA., Although 0.1 mM ppGpp 
inhibited RNA synthesis by 40% there was no preferential restriction of 
rRNA synthesis. This is consistent with the notion that an additional 
soluble factor is required to mediate ppGpp-dependent specific inhibition 
of rRNA synthesis. 
Muto (1975) used a crude cell lysate to study rRNA synthesis in 
vitro. About 40% rRNA was synthesized in the system. Again, addition of 
ppGpp did not specifically inhibit rRNA synthesis. 
In contrast, van Ooyen e^ al. (1975) found using purified RNA polym­
erase with DNA or nucleoids that ppGpp caused a preferential restriction 
of rRNA synthesis. The percent rRNA made was 5.6% in the absence of 
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ppGpp and 2.5% in the presence of 1.4 mM ppGpp. These figures represent 
unbiologically low percentages of rRNA. indicating that factors which allow 
the cell to synthesize 40% rRNA. are missing from the assay. Also, errors 
inherent in the hybridization analysis used to calculate percent rRM in 
the transcripts makes the findings all the more suspect. More recently, 
van Ooyen et al. (1976) reported the specific inhibition of rRNA. synthesis 
with ppGpp from XdSilv DNA which carries an rRNA. cistron. The percent 
rRNA made was 23.8% and 8.6% in the absence and presence of ppGpp, re­
spectively. These figures are more significant than in the previous study. 
However, the relationship of studies involving highly purified components, 
including an unnatural template, to the situation vivo remains to be 
determined. Also, since 8% of XdSilv codes for rRNA, in the absence of 
ppGpp these genes are only being transcribed three times more efficiently 
than the other genes on XdSilv DNA. In sharp contrast, rRNA genes make up 
about 0.4% of the genome and yet account for 40% of the transcription in 
vivo. This means there is a one hundredfold preferential transcription in 
vivo as compared to a threefold enhancement in the system of van Ooyen 
et al. (1976). Clearly the authors were experimenting under nonphysio-
logical circumstances. 
Reiness ^  al. (1975) were the first to demonstrate a preferential 
inhibition of rRNA synthesis vitro with ppGpp in a system capable of 
making high levels of rRNA from whole E. coli DNA. A crude, dialyzed 
S-100 (i.e., a supernatant from a 100,000 x g centrifugation of an coli 
extract) supplemented with coli DNA, nucleotides and other factors was 
used to synthesize RNA. About 25% of the RNA synthesized was rRNA. Two 
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lig/ml rifampicin totally inhibited rRNA synthesis indicating the system 
initiates new synthesis of rKNA. Addition of 0.2 mM ppGpp inhibited over­
all RNA. synthesis by 55% while inhibiting rRNA. synthesis by about 90%. 
Other genes were also examined. tRM. synthesis was only moderately 
(25-50%) inhibited whereas lac and trp opérons were stimulated by ppGpp. 
In separate in vitro studies, ppGpp stimulated arg, lac, trp (Yang et al., 
1974) and his (Stephens et al., 1975) opérons while inhibiting the arg 
operon (Yang et al., 1974). Also, Lindahl et al. (1976) demonstrated in 
vitro inhibition of ribosomal proteins, EF-G, EF-Tu, rKNAs, and RNA 
polymerase subunit a by ppGpp. This latter system employed DNA, UNA 
polymerase and an S-100 fraction. The authors found that ppGpp gave a 
much greater inhibition of transcription using X DNA containing many genes 
for transcription and translation than using unmodified X DNA. This effect 
was abolished in the absence of the S-100 fraction. This was interpreted 
as evidence for an additional factor involved in the control of transcrip­
tion by ppGpp. 
This theory gains considerable support from the work of Block (1976). 
He found that some component (s) of a fractionated coli SlOO which was 
eluted just after RNA polymerase on a Sephadex G-lOO column was able to 
enhance the preferential transcription of rRNA using RNA polymerase and 
DNA. This rRNA synthesizing activity was inhibited by ppGpp. A model 
which could account for these results includes a positive activator of 
rRNA synthesis that is antagonized by ppGpp. 
Travers (1976) has proposed a model whereby RNA polymerase is capable 
of assuming different conformations with different transcribing 
35 
specificities. ppGpp would shift KNA polymerase to a conformation un­
favorable for the transcription of rRNA genes. Other factors in the cell, 
such as TuTs, would also affect RNA. polymerase conformation. 
At least in the case of rRNA regulation, the evidence strongly favors 
the presence of a protein factor in addition to ppGpp, RNA. polymerase and 
DNA. Block's factor is a good candidate for this regulatory factor (Block, 
1976). A possible mode of action for the factor not previously tested is 
a physical alteration of RNA polymerase under the control of ppGpp. There 
are many instances in the literature where changes in RNA polymerase 
structure have resulted in an alteration in transcription: (1) ADP-
ribosylation by a T4 NAD*'": Protein ADP-ribosyltransferase (Rohrer ^ t al., 
1975; Mailhammer et al., 1975); (2) phosphorylation by a T7 protein kinase 
(Zillig et al., 1975); and (3) addition of polypeptides during sporulation 
in subtilis (Linn et al., 1975). In addition, Zillig et al. (1976) 
have reported that phosphate starvation induces phosphorylation of the a 
subunit of RNA polymerase in coli. The possibility that ppGpp struc­
turally modifies RNA polymerase either directly by moiety transfer or 
indirectly by stimulating a protein kinase has been examined and ruled out 
(see Results and Discussion). These findings reinforce the possibility 
that the regulatory factor involved in rRNA regulation involves direct 
binding to the rRNA promoters or to RNA polymerase itself. 
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MATERIALS AND METHODS 
Isolation and Culture of Preimplantation 
Mouse Embryos 
CF-1 mice (Charles Rivers Breeding Labs) were superovulated by in­
jecting 5 lU pregnant mare serum (PMS) (Organon) and then 5 ID human 
chorionic gonadotropin (HCG) (Nutritional Biochemical) 48 h later. 
Blastocyst stage embryos were flushed from uteri between 4 and 4.5 days 
of gestation according to Rafferty (1970). Embryos were collected and 
cultured in Whitten and Biggers (1968) medium. Incubations were done at 
37*C in an atmosphere of 5% CO2 in air under a layer of paraffin oil pre-
equilibrated with medium. For the experiment shown in Figure 1, 150 
blastocyst stage embryos were incubated in 200 ^ il of medium containing 
0.5 mCi (^^P)-orthophosphate (^^PO^) (New England Nuclear) for 3 h. 
Medium lacking KSgPO,^ was used to increase the specific activity of the 
nucleotide pool. At the end of the incubation, the embryos were washed 
3 times in 100 lil unlabeled medium and then extracted with 15 Ul 2N formic 
acid. The extract was freeze-thawed, chilled in ice, and centrifuged at 
3,000 X g for 5 min. The supernatant was transferred to a clean tube. 
Five Ul of 20 mM bacterial ppGpp (a gift from M. Cashel) was added as an 
internal marker. The entire volume was then spotted on a polyethyleneimine 
(PEI)-cellulose sheet (Brinkman Instruments, Inc.). Chromatography was 
in two dimensions by a modification of the technique of Cashel and 
Kalbacher (1970). 3.3M ammonium formate-4.2% boric acid (pH 7.0) was used 
in the first dimension and 1.5M KH^PO^ (pH 3.4) in the second dimension. 
Paper wicks (Whatman No. 1) were attached by stapling and the solvents 
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developed to 6 cm on the wicks in both dimensions. Spots containing 
were visualized by exposing a sheet of medical x-ray film (Kodak) to the 
chromatogram for 24 h. The position of the unlabeled ppGpp was determined 
using an ultraviolet lamp (Ultra-Violet Products, Inc.). 
Blastocyst stage embryos were labeled with [8-^H]-guanine. Fifty 
blastocysts plus 50 jaCi I8-^H] guanine (Amersham/Searle) were incubated 
in a final volume of 100 yl Whitten and Biggers medium for 5 h at 37°C 
under 5% COg. The embryos were washed, extracted and prepared for chroma­
tography as described previously. Chromatography was in one dimension on 
PEI-sheets in 1.5M KHgPO^ (pH 3.4). The chromatogram was cut into strips 
0.25 cm by 2.0 cm and each strip was counted in 5 ml scintillation fluid 
(19 g PPG and 1.14 g POPOP in 1 gal toluene). The radioactivity was 
determined on a Packard model 3320 scintillation spectrometer. 
Charcoal Extraction of Embryo Extracts 
One hundred-fifty blastocysts were labeled in 150 ul of medium con­
taining 100 liCi ^^PO^ for 3 h at 37°C. The reaction was terminated with 
50 lil 2N formic acid, chilled in ice and centrifuged 3,000 x g for 5 min. 
A 40 yl aliquot of the supernatant was added to 2 mg of acid-washed, 
activated charcoal. The charcoal was then pelleted by low speed centrifu-
gation. Ten Ul of both the charcoal supernatant and the untreated embryo 
extract were spotted on a PEI-sheet and developed with 1.5M EH^PO^ (pH 
3.4). Strips, 0.5 cmr-by-2.0 cm, were cut from the chromatogram and 
counted. 
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Isolation and Culture of Postimplantation 
Mouse Embryos 
Ten- and eleven-day embryos from superovulated mice were isolated as 
described by New and Stein (1964). Uteri were rinsed in Tyrode saline and 
then transferred to a dilute embryo extract (containing penicillin and 
streptomycin at 50 yg/ml). This was prepared by homogenizing 3 parts of 
1.0% glucose in Tyrode to 1 part mouse embryo and then centrifuging at 
9,000 X g for 15 min. The embryos were isolated with their embryonic 
membranes intact. Reichert's membrane was removed, after which the emr-
bryos were transferred to mouse serum according to New (1966). This also 
contained 50 ]ig/ml penicillin and streptomycin. Three embryos were placed 
in a concavity dish with 1.5 ml of mouse serum, which was either undialyzed 
or dialyzed overnight against water. To this was added 0.5 mCi 
The embryo culture was then incubated in an atmosphere of 60% O^, 5% COg 
at 37°C for 3 h. The embryonic membranes were then removed, and the 
embryos were washed in Tyrode saline and homogenized in 100 ]il 10% mono-
chloroacetic acid. Bacterial ppGpp was found to be stable in 10% mono-
chloroacetic acid (data not shown). The embryo homogenates were chilled 
in ice and centrifuged at 1,000 x g for 5 min. The supernatant was 
chromatographed by streaking over a distance of about 10 cm on a PEI-
cellulose sheet. Chromatography was done in 1.5M KHgPO^, pH 3.4, after 
which the chroma to grams were dried and cut into 0.5 cm x 10.0 cm strips 
perpendicular to the direction of elution. Each strip was then counted 
in 10 ml scintillation fluid. 
39 
Preparation of Ribosomes 
Mouse embryonic ribosomes were prepared from embryos collected and 
frozen (-70°C) over a 2-week period from superovulated mice essentially 
as described by Irr et al. (1974). Embryos were suspended in buffer A 
(0.05M Tris-HCl, pH 7,6, O.IM NH^Cl, 0.005M magnesium acetate, 0.005M 
2-mercaptoethanol, and 0.25M sucrose) and homogenized in a glass, hand 
homogenizer. These materials were centrifuged at 12,000 x g for 10 min. 
The pellets were resuspended in buffer A, homogenized a second time, and 
recentrifuged at 12,000 x g for 10 min, and the supernatants were combined 
and made 1% with Triton X-100. The pellets obtained from centrifugation 
at 45,000 rpm for 2 h in a Type 50 Beclaaan rotor were resuspended in buffer 
B (0.05M Tris-HCl, pH 7.6, 0.24M KCl, O.OIM magnesium acetate, 0.005M 2-
mercaptoethanol, and 0.25M sucrose). These materials were cleared at 
12,000 X g for 10 min, and the ribosomes were pelleted again at 45,000 rpm 
for 2 h. The ribosomes were resuspended in buffer C (0.05M Tris acetate, 
pH 8.0, 0.015M magnesium acetate, 0.06M potassium acetate, 0,027M ammonium 
acetate, O.OOIM dithiothreitol, and 0.2 mM sodium EDTA). Adult mouse and 
rat liver cytoplasmic ribosomes were prepared in the same manner. coli 
strain NF58 ribosomes were prepared as described by Cashel (1974). 0.5M 
NHj^Cl ribosomal wash (the source of stringent factor) and high-salt-washed 
ribosomes were prepared from jE. coli NF58 ribosomes according to Haseltine 
et al. (1972). 
Mitochondria were prepared from mouse and rat liver by the method of 
Avadhani eit al. (1974). The mitochondrial pellets were suspended in buffer 
C. Mitochondrial lysis was achieved using Triton X-100 as described by 
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de Vries and van der Koogh-Schuuring (1973). The mitochondrial ribosomes 
were pelleted by centrifuglng at 100,000 x g for 2 h, The pellet was re-
suspended in buffer C and layered on an equal volume of buffer C made 40% 
sucrose and recentrifuged at 100,000 x g for 17 h. The resulting pellet 
was resuspended in a small volume of buffer C. 
In Vitro Polypeptide Synthesis 
Mouse ribosome preparations were tested for vitro polypeptide 
synthesis by a modification of the procedure described by Staehelin and 
Falvey (1971). pH 5 enzyme and SlOO were prepared from adult mouse liver. 
The incubation mixture contained per ml in buffer C: 1 }imole ATP, 0.4 
limole GTP, 10 ymole phosphoenolpyruvate, 10 yg pyruvate kinase, 0.2 ml pE 
5 enzyme, 0.2 ml SlOO, 20 Aago units of ribosome, 380 ug polyuridylic 
acid, and 1.0 Ci (^**0)-phenylalanine (New England Nuclear). Assays were 
done in a total volume of 0.1 ml at 35°C. At 10 min and 20 min 40 Vl 
samples were removed to 5 ml 10% trichloroacetic acid, heated at 90°C for 
10 min, and filtered on B-6 Selectron membrane filters (Scheicher and 
Schuell, Inc.). These were washed 3 times with 5 ml hot 10% trichloro­
acetic acid and once with 50% ethanol. The filters were dried and the 
radioactivity determined in 5 ml scintillation fluid as described previous­
ly. 
Ribosome-Dependent ^  Vitro ppGpp Assay 
Ribosomes were assayed for ppGpp synthesis according to Cashel (1974). 
The incubations were done in buffer C containing 2 mM GTP, 4 mM ATP, 
5 UCi [8-^H] GTP (Amersham and Searle) or 0.1-0.2 yCi (a-^^P) GTP (Amersham 
and Searle) and 1.0 Aggg unit of ribosome (unless stated differently in 
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figure legends) in a total volume of 50 Ul. When present, polyuridylic 
acid (Sigma) and E, coli tKNA. (Sigma) were at 1 mg/ml. Complementation 
with stringent factor was done by adding 10 Ug coli NF58 0.5M NHj^Cl 
ribosomal wash as described by Haseltine et al» (1972). Unless indicated 
differently, the incubations were at 37*C for 1 h and were terminated with 
1 pi 90% formic acid. The reaction mixtures were chilled in ice 15 min 
and centrifuged at 1,100 x g for 5 min. Ten yl of supernatant were spotted 
on PEI-cellulose sheets. Chromatography was done in 1.5M KHgPO^^ (pH 3.4). 
The ^H-labeled materials on the chromatograms were determined by cutting 
2.0 cm X 0.5 cm strips and counting each strip in 5.0 ml scintillation 
fluid. Chromatograms from assays containing (a-^^P) GTP were exposed to 
x-ray film to visualize ^^PO^-labeled nucleotides. The radioactive spots 
were cut out and counted in 5 ml scintillation fluid. 
Partial Hepatectomy of Rats 
Partial hepatectomies were done according to Higgins and Anderson 
(1931). The animals were anesthetized with ether and shaved. Median line 
incisions were cut reaching 3 to 4 cm posteriorly from the xiphoid process 
of the sternum. Left-lateral incisions were made at the anterior end of 
the first incision. The large left lobes of the livers were tied-off and 
excised. The peritoneum and abdominal muscles were closed with two 
sutures of nylon thread and the integument was closed with staple-clamps. 
The animals were provided with 20% dextrose for 24 h and then fed on lab 
blox. Livers were isolated at 3- and 7-days after the operations. 
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Chloroplast Assay for Guanosine Polyphosphates 
Zea mays chloroplasts isolated according to Nobel (1974) were a gift 
from P. Mascia. 2.3 mg of chloroplasts in 50 jil isolation medium were 
incubated with 100 yCi 3^P0\ at 30°C for 1 h in the presence and absence 
of light and 10 mM GDP plus 10 mM ADP. The chloroplast reaction mixtures 
were extracted with 5 Ul 90% formic acid, chilled in ice 15 min, and cen-
trifuged at 1,100 x g for 5 min. Fifteen ill of the supernatant fraction 
was spotted on PEI-sheets and developed in one dimension with 1.5M KH2P0^ 
(pH 3.4) or in two dimensions with 3.3M ammonium formate-4.2% boric acid 
(pH 7.0) followed by 0.85M KH^PO^ (pH 3.4). 
Labeling Mouse Lymphocyte Line GF43 with 
[8-^H3 Guanine or [2-^E} Adenine 
Three ml of exponentially growing cells of mouse lymphocyte line GF43 
at 6 X 10^ cells per ml were labeled with either 50 yCi [8-^H] guanine 
(1 Ci/mmol) (Amersham/Searle) or with 50 UCi [2-^B.] adenine (18 Ci/mmol) 
(Amersham/Searle). The cells were grown in Fishers medium containing 
10% horse serum. The incubation was at 37°C for 8 h. The cells were 
centrifuged down in a table-top centrifuge and extracted with 10 Ul 10% 
monochloroacetic acid. The extract was chilled in ice 15 min, centrifuged 
at 1,100 X g for 5 min and 10 ul of the supernatant fraction spotted on 
PEI-sheets and developed in 1.5M KH^PO,^ (pH 3.4). The distribution of 
label on the chromatograms was determined by cutting the chromatograms 
into strips and counting each strip. 
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Bacterial Strains and Media 
The following coli K12 strains were used: CP78 (argH, thr, leu, 
his, thi, relA**", spoT^), 10B6 relA^ and relA (valS^^, thyA) ; NF58 (relA*^ 
met, argA, spoT*) ; NP29 (relA**", valS^^) ; and NF161 (metB, argA, relA**", 
spoT)» Strain NF161 was a gift from J. Gallant. 
Cells were grown in Tris-glucose mineral medium (Irr and Gallant, 
1969) supplemented with 1 ]ig/ml thiamine and either 0.2% casamino acids 
or a mixture of 18 amino acids (all except phenylalanine and glutamine) 
ranging in concentrations from 4 Ug/ml to 18 yg/ml depending on their 
molar ratios in protein. For experiments involving labeling of 
nucleotides, media containing 50 yM potassium phosphate and 2 mM KCl was 
used. 
Measurement of KNA., Protein and DNA. Synthesis In Vivo 
Strain CP78 was grown in Tris-glucose media containing 2 mM potassium 
phosphate for the determination of RM, protein and DNA synthesis. The 
isotopes were added to growing cultures at densities of about 5 x 10^ 
cells/ml. After 1.5-to-2 doublings samples were taken for the determina­
tion of isotope incorporation. Immediately after taking the 3rd sample, at 
15 min, the cultures were divided into several parts containing varying 
concentrations of 5a,6-anhydrotetracycline as indicated in the legend to 
Figures 10, 11 and 12. 
RNA synthesis in strain CP78 was determined using ^^PO^ by an adapta­
tion of the method of Roodyn and Mandel (1960). The method takes the 
difference between total trichloroacetic acid (TCA)-precipitable, alcohol-
insoluble counts and the alkali stable counts (primarily DNA) as the amount 
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of radioactive label in RNA.. At the times indicated in Figure 2, 1 ml 
samples of the culture were taken to both 1 ml 10% TCA (0*C) and 1 ml IN 
NaOH. The TCA samples were filtered on microporous membrane filters 
(0.45 yM) (Amicon) and washed with 5 ml 5% TCA (0®C) three times then once 
with 5 ml 50% ethanol (0®C). The NaOH samples were placed at 37°C for 
15 h and then filtered and washed as described above. The filters were 
dried and counted with 5 ml scintillation fluid. The specific activity of 
the in the media was taken to be the same as that in the KNA. 
Gallant and Harada (1969) have reported that exogenous ^^PO^ is totally 
equilibrated with the triphosphate pools in about a half a generation. 
Protein in strain CP78 was determined with (^H)-phenylalanine 
(Amersham/Searle) at 0.2 UCi/ml with 0.2% cas ami no acids in the media. 
One ml samples were taken to 1 ml 10% TCA at the indicated times (Figure 
11). The samples were heated at 100° C for 15 min, filtered on microporous 
filters and washed with 5 ml hot 5% TCA three times. 
DNA was measured using (^H-methy 1)-thymidine (Amersham/Searle) at 
14.3 Ci/mole. One ml samples were taken to 1 ml 10% TCA (0°C). The 
samples were filtered on microporous filters, and washed with 5 ml 5% TCA 
(0°C) three times. 
RNA and protein synthesis in 10B6 relA (Figure 13) was determined by 
growing cells in media containing 0.1 yCi/ml (^H)-uridine (New England 
Nuclear) and 0.01 yCi/ml (^**C)-phenylalanine (New England Nuclear). The 
media also contained 20 yg/ml uridine and 0.2% casamino acids. One ml 
samples were taken to 1 ml 10% TCA (0°C) filtered three times with 5 ml 
5% TCA (0°C) and then washed. 
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Measurement of KNA. Synthesis ^  Vitro 
RNA synthesis i^ vitro was determined according to Cashel (1970). 
E. coli strain NF58 DM. at 40 yg/ml was used as template. jE. coli K12 
strain PR-7 (Sm^, Lac", KNasel , PNPase ) RNA. polymerase (Miles Laborator­
ies, Inc.) was used at 14.9 units or 18.8 iig per ml of the assay mixture. 
The assays, initiated by adding the enzyme, were done at 37°C. Fifty yl 
aliquots were taken to 5 ml 5% TCA with 40 mM (0°C) at the times 
indicated in Figure 14. The samples were filtered and washed with 5 ml 
5% TCA, 40 mM KE^PO^ (0°C) 2 times. 
Measurement of Ribonucleoside Triphosphate Levels 
Strain CP78 was grown in Tris-glucose media containing 50 yM potassium 
phosphate and a mixture of 18 amino acids. Two hundred yCi/ml ^^PO^ was 
added to a growing culture at 7.5 x 10^ cells/ml. When the culture reached 
a density of 1.7 x 10® cells/ml, 20 yg/ml 5a,6-anhydrotetracylcine was 
added to an aliquot of the culture. Ten min later 100 yl samples of the 
two aliquots of cells were added to ice-cold tubes containing 5 yl 90% 
formic acid. The formic acid extracts were centrifuged at 1,100 x g for 
5 min and 15 yl of the supernatant was spotted on a polyethyleneimine 
(PEI)-cellulose sheet (Brinkman). Chromatography was in two dimensions 
according to Cashel et al. (1969). The first dimension was 3.3M ammonium 
formate + 4.2% boric acid adjusted to pH 7.0 with NSi^OS. The chromatogram 
was then soaked in methanol for 15 min, dried and developed in the second 
dimension with 0.8M KB^PO^ (pH 3.4). The chromatograms were exposed to 
medical x-ray film overnight to visualize the ^Zpo^-labeled nucleotides. 
Authentic ATP, GTP, CTP and UTP (Sigma Co.) was added to an aliquot of the 
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supernatant fraction and chromatographed as described above. These com­
pounds were visualized by an ultraviolet light and their positions used as 
an internal standard. These positions, corresponding to spots on the x-ray 
film (Figure 15), were cut out and counted in 5 ml scintillation fluid. 
Nonribosomal Synthesis of ppGpp 
by Stringent Factor 
Stringent factor from coli K12 (Grain Processing Corporation, 
Muscatine, Iowa) was prepared and assayed by the method of Sy et al. 
(1973). Fraction I stringent factor was used. [8-^H] GTP (Amersham/ 
Searle) was at 250 Ci/mol in the assays which were at 28°C for 5 h. Ten 
yl aliquots of the supernatant fraction were spotted on PEI-cellulose 
chromâtograms. After the chromatograms were developed with 1.5M KH^PO^ 
(pH 3.4), they were cut into 2.0 by 0.5 cm strips and each strip counted 
in 5 ml scintillation fluid. 
Measurement of ppGpp and pppGpp 
Synthesis ^  Vivo 
Strain 10B6 rel^ (valS^^) was grown in Tris-glucose media containing 
50 yM potassium phosphate at 30°C. One hundred uCi/ml was added to 
a growing culture at 7 x 10^ cell/ml. Fifty yl samples were taken to ice-
cold tubes containing 2.5 yl 90% formic acid after shifting to 42°C at 
1.8 X 10® cells/ml as indicated in the legends to Figures 16 and 17. The 
formic acid extracts were centrifuged at 1,100 x g for 5 min and 10 yl of 
the supernatant was spotted on a PEI-cellulose sheet and developed in 1.5M 
KHgPO.^ (pH 3.4). 32po%-labeled nucleotides were visualized by exposing 
the chromatogram to medical x-ray film overnight. ppGpp and pppGpp were 
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quantitated by cutting out the spots and counting in 5 ml scintillation 
fluid. 
Measurement of the Decay of 
ppGpp in a spoT Strain 
Strain NF161 (rel^, spoT) was grown in Tris-glucose media containing 
50 ]iM potassium phosphate and 5 Vg/ml arginine at 21°C. One hundred liC/ml 
was added to growing cells at 8.5 x 10^ cells/ml. Twenty min after 
the culture ceased growing due to exhaustion of arginine (about 1.6 x 10® 
cells/ml), 100 yg/ml arginine was added to alxquots of the culture in the 
presence or absence of 5a,6-anhydrotetracycline and manganese as described 
in the legend to Figure 19. Samples were taken and ppGpp levels determined 
as described above. 
Antibiotics 
5a,6-Anhydrotetracycline was a generous gift from Dr. J. H, Boothe, 
Lederle Laboratories. Tetracycline and rifampicin were purchased from 
Sigma Co. and oxytetracycline was purchased from Pfizer. 
Precipitation and Electrophoresis of KNA 
Polymerase from Labeled Cell Extracts 
Rabbit anti-^. coli RNA polymerase was prepared according to Linn 
et al. (1973). coli RNA polymerase (Sigma Co.) was injected into a 
New Zealand White rabbit. Precipitation of RNA. polymerase with the anti­
body was by the method of Zillig et al. (1975). The precipitated KNA 
polymerase was suspended in Laemmli (1970) sample buffer. This was sub­
jected to electrophoresis on 5% aerylamide-SDS gels (Maizel, 1956). The 
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gels were stained in 0.25% Coomasie Blue, 91% methanol and 9% acetic acid 
overnight followed by destaining in 7.5% acetic acid. Autoradiograms of 
gels were prepared by slicing the gels in half lengthwise, drying in a 
vacuum oven at 100°C on filter paper and exposing to x-ray film overnight. 
Dansylation of RNA. polymerase was done by adding 5 ill 1.35 mg/ml dansyl 
chloride (Sigma) in acetone to 50 yg RNA polymerase in 50 Ul 0.2M Tris-
C1 (pH 8.2), 0.2% SDS. This was incubated for 20 min at 25*C. The pro­
tein was precipitated by adding 220 ill of 100% acetone. 
labeling of strain NP29 was done by growing the cells in 50 yM 
potassium phosphate Tris-glucose mineral medium (Irr and Gallant, 1969) 
containing 50 yCi/ml Cells were grown at 30°C and shifted to 42®C 
to induce ppGpp synthesis. The cells were lysed and the RNA. polymerase 
precipitated according to Zillig ^  al. (1975). 
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RESULTS AND DISCUSSION 
The Search for ppGpp in Eukaryotes 
In order to determine whether guanosine polyphosphates or other 
unusual highly phosphorylated nucleotides are present in organisms other 
than prokaryotes, two main approaches were followed. First, controversial 
reports in the literature claiming to have found ppGpp in one or more 
eukaryotic system were investigated. Some of these studies were repeated 
in an attempt to assess their validity. Additional experiments were de­
signed and carried out to elucidate pitfalls in the original works. 
Second, eukaryotic systems which seemed most likely to produce ppGpp were 
examined. 
Before describing the data, a few points concerning nucleotide hunt­
ing expeditions should be considered. Gallant and Margason (1972) point 
out the hazards of identifying nucleotides solely on the basis of one-
dimensional chromatography, a warning often ignored by researchers in the 
field. They found an adenine containing nucleotide in Bacillus subtilis 
which comigrated with ppGpp in one dimension using KH2P0,j but was resolved 
from ppGpp in other chromatographic systems. In addition, condensed in­
organic phosphate or polyphosphate is ubiquitous in nature (Harold, 1966) 
and can easily be mistaken for nucleotides in one-dimensional chromato-
grams of labeled cell extracts. Also, contamination of eukaryotic 
cells with bacteria or mycoplasma must be rigorously avoided. 
In vivo assays for ppGpp usually consist of culturing the organism 
or cells in ^*20%, extraction with acid (usually formic acid), and finally 
thin-layer chromatography of the extract. Various techniques are employed 
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to induce ppGpp synthesis ^  vivo. By analogy to bacteria, amino acid or 
nutrient starvation is frequently the method of choice. The ^  vitro 
assay for ppGpp is an assay for a ppGpp-synthesizing enzyme and usually 
involves ribosomes. Crude cell extracts, however, are also used. 
Mouse embryos fail to synthesize detectable quantities of guanosine 5*-
diphosphate 3'-diphosphate 
Irr et al. (1974) have reported that ribosomes derived from 10- and 
11-day mouse embryos were capable of synthesizing ppGpp in amounts compar­
able to jE. coli ribosomes, whereas ribosomes from 14-day embryos or from 
adult mouse tissue were inactive. That report implies a role for ppGpp 
in the development of the mouse. I have been unable, however, to detect 
any ppGpp synthesis in cultured pr eimplantat ion and post implantation mouse 
embryos or in assays using 10- to 13-day mouse embryonic ribosomes. Three 
unidentified phosphorous containing compounds that migrate slower than GTP 
on PEI-cellulose chromatograms have been discovered in mouse blastocysts. 
At least two of these compounds are quantitatively absorbed by activated 
charcoal and hence probably contain an aromatic ring. 
Mouse embryos were cultured in the presence of ^^PO^ in an attempt to 
detect ppGpp synthesis. Figure 1 is an autoradiogram of a two-dimensional 
PEI-cellulose chromatogram prepared using a formic acid extract of blasto­
cyst stage mouse embryos labeled with ^^PO^ to which unlabeled bacterial 
ppGpp was added as an internal marker. The dotted circle marks the posi­
tion where the bacterial ppGpp migrated as determined using a short wave­
length ultraviolet lamp. This was verified on separate chromatograms 
using ^^POjj labeled extracts of coli (data not shown). As shown in 
Figure 1. An autoradiogram from a two-dimensional PEI-cellulose chromatogram of an 
extract of labeled blastocyst stage mouse embryos. The dotted circle 
shows the position where internal marker ppGpp migrated 
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Figure 1, the blastocysts did not accumulate a detectable amount of label 
in the region where the ppGpp migrated. Also, no spot appeared in the 
region where pppGpp migrates (not shown). Three as yet unidentified sub­
stances, Al, A2, and B were discovered (Figure 1). These were not con­
taminants in the because chromatograms prepared using spotted 
directly from the stock solution did not show any label in the regions of 
Al, A2, and B. Al and A2 migrate very close to each other and may repre­
sent a single substance. Spot B migrates to a position near ppGpp and may 
represent a compound similar in structure to ppGpp, such as an isomer or 
methylated form of ppGpp. Because spots Al, A2, and B represent only 0.8, 
1.9 and 0.3 percent respectively of the label found in GTP, we have been 
unable to determine conclusively whether ^H- and ^**0-labeled nucleosides 
will serve as precursors to the spot compounds. Figure 2 illustrates this 
point. Mouse blastocysts were incubated in media containing [8-^H] guanine 
in an attempt to determine if Al, A2 or B contained this nucleobase. 
Fifty embryos were incubated with 50 liCi [8-^H] guanine at 37°C for 5h. 
Figure 2 shows the distribution of radioactivity on a PEI chromatogram of 
the entire extract from the fifty embryos. The GTP peak contains 1,298 
cpm. Al plus A2 make up only 2.7% of the ^^PO^ cpm of GTP (Figure 1). 
Therefore if one assumes that the PO^-to-guanine ratio in GTP is approxi­
mately that of Al and A2, there would be only 2.7% of 1,298 or 35 cpm in 
the A1-A2 region of the chromatogram in Figure 2. Although no such peak 
exists in Figure 2, a peak of 35 cpm is near the lower level of detection 
by this method. 
Figure 2. The distribution of label on a chromatogram of blastocyst stage mouse 
embryos labeled with [8-^H] guanine. The arrow indicates the position 
where mouse spots A1 and A2 migrate 
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An. indication that at least A1 and A2 may be nucleotides is shown 
in Figure 3. An extract from labeled mouse blastocysts was divided 
into two aliquots. One aliquot was absorbed with activated charcoal. The 
charcoal was then centrifuged, and the supernatant spotted on a PEI-sheet 
alongside the other, untreated, aliquot. As seen in Figure 3, compounds 
A1 and A2 are absorbed by charcoal, hence they probably contain an aromatic 
ring. Since they also contain PO^, they may be nucleotide in nature al­
though the proof for this awaits further chemical characterization. 
ppGpp was also absent from embryos cultivated at later stages of 
development. Figure 4 is the distribution of label on one-dimensional 
PEI-cellulose chromatograms using extracts from 11-day mouse embryos cul­
tured in ^^PO^ as described in Materials and Methods. The arrow indicates 
the position where ppGpp was found to migrate on separate chromatograms. 
As shown in Figure 4 (closed circles) the 11-day embryos did not accumulate 
a detectable quantity of ppGpp while synthesizing a significant amount of 
labeled GTP. Ten-day embryos gave similar results (data not shown). This 
procedure would have revealed ppGpp in amounts of less than 5% of the GTP 
label. To determine whether conditions of nutritional deficiency would 
induce the synthesis of ppGpp in 11-day mouse embryos, dialyzed serum was 
used as the culture medium. As seen in Figure 4 (open circles), no ppGpp 
was detected using these conditions. Incorporation of label into GTP was 
greater when dialyzed serum was used as the culture medium because of 
greater specific activity of the ^^PO^. 
Spots Al, A2, and B found in the preimplantation mouse embryos (see 
Figure 1) would probably not be detected here because of their relatively 
Figure 3. The distribution of label on chromatograms of labeled 
mouse blastocyst extracts preabsorbed with charcoal (^) or 
untreated (0)« The arrow indicates the position where 
mouse spots Â1 and Â2 migrated 
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low concentrations, all represent less than 2 percent of the label found 
in GTP. 
Ribosomes from 10- to 13-day embryos and from adult mouse liver were 
isolated as described in Materials and Methods for use in ppGpp assays. 
These ribosomes were first tested for in vitro polypeptide synthesis. As 
shown in Table 2, all the embryonic ribosome preparations actively synthe­
sized polypeptide in amounts comparable to that obtained with adult mouse 
liver ribosomes. Therefore, the ribosomes were found suitable for ppGpp 
assays. 
The results of the ppGpp assays are shown in Table 3, column 1. None 
of the embryonic ribosomes accumulated significantly more label in the 
regions where pppGpp and ppGpp migrate than was found using no ribosomes 
in the assay, line 1. The small amount of label found in the region where 
ppGpp migrates in the absence of ribosomes is an impurity in the commercial 
[8-^H] GTP used. By comparison, a large amount of ppGpp is synthesized 
with coli ribosomes. 
In jE. coli, ppGpp is synthesized by a ribosome associated enzyme 
called stringent factor (Block and Haseltine, 1975). This enzyme is 
present in ribosomal high-salt-washes from stringent strains of JE. coli 
(Haseltine et al., 1972). To test the possibility that a "stringent 
factor-like" protein may have been lost or inactivated during the prepara­
tion of embryonic ribosomes, jE. coli NF58 ribosomal high-salt-wash was 
used to complement the ribosomes in ppGpp assays. Table 3, column 2. 
coli ribosomal high-salt-wash alone synthesized a small amount of ppGpp 
and pppGpp. This is consistent with the observation of Sy et al. (1973) 
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Table 2. Polyuridylic acid directed polyphenylalanine synthesis using 
mouse embryonic ribosomes as described in Materials and Methods 
CPM 
Ribosome preparation 
10 min 20 min 
None 94^ 105 
10 day embryo 726 1312 
11 day embryo 875 1541 
12 day embryo 894 1876 
13 day embryo 1107 1703 
Liver 952 1872 
^All values shown are an average of two separate assays. 
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Table 3. ppGpp assays using ribosomes in the presence and absence of 
JE. coli NF58 ribosomal high-salt-wash as described in Materials 
and Methods 
CPM 
E. coli ribosomal high-salt-wash ^ 1 2 
+ 
Additions 
1. None pppGpp 126 405 
ppGpp 462 721 
2. E, coli ribosomes pppGpp 648 
ppGpp 4,675 
3. coli high-salt washed ribosomes PPpGpp 114 501 
ppGpp 490 2,613 
4. 10 day embryonic ribosomes pppGpp 143 495 
ppGpp 515 863 
5. 11 day embryonic ribosomes pppGpp 144 410 
ppGpp 475 747 
6. 12 day embryonic ribosomes PPpGpp 77 472 
ppGpp 412 989 
7. 13 day embryonic ribosomes PPpGpp 129 435 
ppGpp 444 712 
8. Adult mouse liver ribosomes pppGpp 322 
ppGpp — 647 
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that stringent factor will catalyze the slow formation of ppGpp in the 
absence of ribosomes. Haseltine e^ al. (1972) have demonstrated that 
high-salt-washed coli ribosomes, no longer capable of synthesizing 
ppGpp, can be restored by addition of ribosomal high-salt-wash. This is 
shown in the third line of Table 3. Ten- to thirteen-day embryonic ribo­
somes and adult mouse liver ribosomes were assayed in the presence of 
coli ribosomal high-salt-wash. Table 3. The stringent factor appears to 
have been slightly stimulated by the 10- and 12-day ribosomes. However, 
the stimulation found using coli high-salt-washed ribosomes with strin­
gent factor is much greater. We conclude that none of the embryonic ribo­
somes significantly enhanced ppGpp synthesis by JE. coli ribosomal high-
salt-wash. In addition, we have tried to synthesize ppGpp using the 
supernatant from a 100,000 x g centrifugation of 11-day embryo extracts 
alone or with 11-day embryonic ribosomes without success (data not shown). 
Thus, we feel it unlikely that a ppGpp synthesizing factor dissociated 
from the embryonic ribosomes. 
In conclusion, the data indicate that preimplantation and postimr-
plantation mouse embryos do not synthesize detectable quantities of ppGpp 
in contrast to the results of Irr et al. (1974). The reason for these 
differences is not understood. Unknown phosphate containing compounds, 
however, are present in blastocyst stage mouse embryos, at least two of 
which may be nucleotide in nature. 
Irr has also been unable to repeat his experiments with mouse embry­
onic ribosomes (J. D. Irr, Genetics Unit, Massachusetts General Hospital, 
Boston, Massachusetts, personal communication, 1976), It appears probable 
that the original data reported by Irr et al. (1974) was spurious. 
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The absence of a ppGpp synthesizing enzyme on mitochondrial and cytoplasmic 
ribosomes isolated from mouse liver and regenerating rat liver 
By analogy to bacteria (Haseltine et al., 1972), if ppGpp were syn­
thesized in eukaryotes one might expect the ribosomes to be the sites of 
synthesis. Mitochondrial ribosomes in particular might be expected to 
resemble bacterial ribosomes in their ability to synthesize ppGpp. This 
is because mitochondrial and bacterial ribosomes share their sensitivity 
to certain inhibitors of protein synthesis, e.g., choramphenicol, erythro­
mycin and streptomycin. Richter (1973) has shown that ribosomes from 
yeast mitochondria were able to slightly stimulate ppGpp synthesis by 
coli stringent factor, whereas ribosomes isolated from yeast cytoplasm, 
reticulocyte and calf brain gave no stimulation. However, others have 
found no stimulation of stringent factor by yeast mitochondrial ribosomes 
(Lund, Pederson and Kjeldgaard, as cited by Block and Haseltine, 1974). 
Horvath et al. (1975) reported ^^PO^-labeled spots were synthesized in 
isolated rat liver mitochondria that comigrated with ppGpp in one dimen­
sion. These spots were stimulated by GDP but not by any other nucleotide. 
Also, Pao et (1977) reported ppGpp synthesis in Saccharomyces cere-
visiae which they attributed to mitochondria. We have isolated cytoplasmic 
and mitochondrial ribosomes from mouse liver to determine if they are 
capable of sustaining ppGpp synthesis or of stimulating ppGpp synthesis by 
coli stringent factor. Also, ribosomes were isolated from regenerating 
rat liver. This was done to determine if a rapidly proliferating tissue 
is capable of inducing ppGpp synthesis. In this regard, Anderson et al. 
(1975) have reported a change in the electrophoretic migration pattern of 
ribosomal proteins during rat liver regeneration. 
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Testing of mouse liver mitochondrial ribosomes for ppGpp synthesis 
in the presence and absence of coli stringent factor Mitochondria 
were isolated from mouse liver by the method of Avadhani et al» (1974). 
This procedure utilizes digitonin to digest the outer membrane removing 
lysosomes and attached cytoplasmic ribosomes. The mitochondrial and cyto­
plasmic ribosomes were prepared as described in Materials and Methods and 
assayed in the presence and absence of coli stringent factor. 
Figure 5 illustrates the complete absence of ppGpp or pppGpp synthesis 
by cytoplasmic and mitochondrial ribosomes (samples C and E respectively) 
under conditions where the coli ribosomes (sample A) converted nearly 
all of the [a-^^P] OTP to the guanosine polyphosphates. Samples B and D 
show the synthesis of pppGpp and ppGpp by stringent factor in the presence 
of cytoplasmic and mitochondrial ribosomes, respectively. In the presence 
of either mitochondrial or cytoplasmic ribosomes, stringent factor cata­
lyzed nearly the same amount of pppGpp and ppGpp as that found with strin­
gent factor alone (not shown). This data is in conflict with the findings 
of Richter (1973). He reported the slight stimulation of stringent factor 
by yeast..mitochondrial ribosomes. 
Absence of ppGpp synthesis by mitochondrial and cytoplasmic ribosomes 
isolated from regenerating rat liver The large left lobes of the rat 
livers were tied off and excised as described in Materials and Methods. 
The regenerating liver was isolated at either 3- or 7-days after the 
operation and the mitochondrial and cytoplasmic ribosomes isolated. Figure 
6 shows the results from the 3-day regenerating liver ribosomes. Sample A 
is the [a-^^P] GTP alone. The results of the coli ribosome assay is 
Figure 5. An autoradiogram of a chromatogram of ppGpp assays with coli NF58 ribo-
somes (A); mouse cytoplasmic rlbosome plus stringent factor (B); mouse 
cytoplasmic ribosomes alone (C)j mouse mitochondrial ribosomes plus 
stringent factor (D); and mouse mitochondrial ribosomes alone (E). Ribosomes 
were present at a concentration of 1.5 mg/ml. The assay was done at 28°C 
for 14 h 

Figure 6. An autoradiogram of a chromatogram of [a-^^P] GTP (A); and ppGpp assays 
with regenerating liver mitochondrial ribosomes (B); coll NF58 rlbo­
somes (C); regenerating liver cytoplasmic ribosomes: alone (D); or with 
polyurldylic acid plus tRNA (E); or with coll NF58 ribosomes (F). 
coll and cytoplasmic ribosomes were at 16 mg/ml and the mitochondrial 
ribosomes were at 2.3 mg/ml. The assay was done at 37°C for 1 h 
I 
ppGpp 
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sample C. As shown, neither the mitochondrial ribo somes (sample B) nor the 
cytoplasmic ribosomes (sample D) synthesized guanosine polyphosphates. 
Addition of tRNA and poly-uridylic acid failed to stimulate the cytoplasmic 
ribosomes (sample E). Also, addition of cytoplasmic ribosomes to the 
coli ribosomes failed to significantly inhibit pppGpp and ppGpp synthesis 
demonstrating the absence of inhibitors in the cytoplasmic ribosome prep­
aration. The ribosomes isolated from the 7-day regenerating liver gave 
similar results. These data demonstrate the absence of a ppGpp synthesiz­
ing enzyme associated with cytoplasmic and mitochondrial ribosomes from 
normal and regenerating liver. 
It is possible that mitochondria synthesize the guanosine polyphos­
phates but the enzyme responsible for their synthesis is either loosely 
associated with the ribosome so that it is lost in isolation or not asso­
ciated with the ribosome at all. In this regard, Sy and Akers (1976) 
reported the isolation of a ribosome-independent guanosine 5',3'-polyphos­
phate synthetase from Bacillus brevis. Perhaps the situation is similar 
with mitochondria. 
In addition to the results presented, ribosomes isolated from Dro-
sophila larvae were also found to be devoid of guanosine polyphosphate 
synthesizing activity. 
The possible presence of pppGpp in Zea mays chloroplasts 
Horvath et (1975) have reported pppGpp synthesis by isolated spin­
ach chloroplasts in the presence of and GDP; no other nucleoside 
diphosphate could substitute for GDP. The characterization of the nucleo­
tide, however, was limited to one-dimensional chromatography. Sy et al. 
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(1974) have shown that Chlamydomonas reinhardtii chloroplasts ribosomes do 
not synthesize guanosine polyphosphates. However, when supplemented with 
coli stringent factor they respond with abundant ppGpp synthesis, a 
property not seen with Chlamydomonas cytoplasmic ribosomes. We have re­
peated in a modified form the experiment of Horvath et al. (1975) using 
Zea mays chloroplasts and find a small but definite spot in the region 
where pppGpp migrates. 
Zea mays chloroplasts were isolated according to Nobel (1974) and 
incubated in the isolation media containing for 1 h at 30°C. The 
results are seen in Figure 7. As shown, the presence of the nucleotides 
greatly stimulated the synthesis of ATP, GTP and a small amount of a com­
pound migrating at the same rate as pppGpp. Light had no effect on the 
labeling of the nucleotides. The slow-moving spot comigrates with authen­
tic pppGpp in two dimensions (data not shown). Bacteria are essentially 
impermeable to nucleoside diphosphates making it unlikely the synthesis of 
the nucleotides are due to bacterial contamination. Also, no bacterial 
strain has been found which synthesizes pppGpp alone. This is because 
pppGpp is converted to ppGpp in bacteria (Fiil et al., 1977). 
Absence of guanosine or adenosine polyphosphates in mouse lymphocyte line 
GF43 
The weight of evidence in the literature favors the absence of ppGpp 
in cultured mammalian cells (Stanners and Thompson, 1974; Mamont et al., 
1972; Fan et al., 1973; Thammana et al., 1976). However, Rhaese (1975) 
daims to have found guanosine and adenosine polyphosphates and other 
compounds in various cell lines. His characterization of these compounds 
Figure 7. An. autoradiogram of a chromatogram of extracts of 2ea mays 
chloroplasts incubated with 10 mM ADP, 10 mM GDP with light 
(A); 10 mM ADP, 10 mM GDP with no light (B); no nucleotides 
added with light (C) ; and no nucleotides added with no 
light (D) 
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ppGpp 
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was based on their ability to be labeled by and their chromatographic 
migration in one dimension. Since polyphosphates are known to be synthe­
sized by mammalian cells (Griffin et al., 1965) the identification of slow-
moving phosphorous containing compounds solely on the basis of one-dimen-
sional chromatography is at best questionable. Using tritiated guanine 
ar>(^ adenine we find that Rhaese's compounds are not present in mouse lym­
phocyte line GF43, at least not at the concentrations claimed. 
Figure 8 shows the distribution of label on chromatograms of GF43 
cell extracts grown in the presence of [8-^H] guanine or [2—^H] adenine. 
No peaks are detected moving slower than the triphosphates. Using CHO and 
BHK cells, Rhaese found ppGpp ^^30% cpm in amounts ranging from 2.4% to 
7.6% of the GTP cpm. This would correspond to between 136 to 431 cpm of 
^H-guanine in Figure 8. Similarly, Rhaese found HPN IV (pppAppp) 
cpm in amounts ranging from 2% to 10.2% of the GTP cpm. Since no such 
peaks of either ppGpp or pppAppp are found, our finding supports the 
literature in favor of an absence of these compounds in cultured mammalian 
cells. In addition, no slow-moving compounds were found using ^^C-labeled 
cytosine and uracil (not shown). 
5a,6-Anhydrotetracycline: Characterization 
of a Drug that Affects ppGpp Metabolism 
and Other Cellular Processes 
The effects of tetracycline on protein synthesis are well-studied 
(see Pestka, 1971, for review). Tetracyclines, however, are also known to 
affect other cellular processes. RNA synthesis is inhibited by high con­
centration of tetracycline. At 500 yg/ml, tetracycline was found to 
Figure 8. The distribution of label on chromatograms of mouse lymphocyte line GF43 
labeled with either [8-®H] guanine (Q) or with [2-®H] adenine (A). 
The arrow indicates the position where ppGpp migrates 
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specifically inhibit rKM synthesis allowing mRNÂ. synthesis to continue 
(Atherly, 1974a). Similarly, 300 lig/ml tetracycline added to a strain of 
coli with temperature-sensitive EFTs at the nonpermissive temperature 
abolished ppGpp synthesis but failed to restore rRNA. synthesis (Glazier and 
Schlessinger, 1974). Tetracyclines are probably the only drugs known which 
directly inhibit the synthesis of ppGpp (Cashel, 1975; Kaplan et al., 
1973). In addition to inhibiting ppGpp synthesis, high concentrations of 
tetracycline also inhibit ppGpp decay, but only in strains that are spoT 
(Stamminger and Lazzarini, 1974). SpoT strains exhibit aberrant ppGpp 
metabolism (De Boer et al., 1977; Chaloner-Larsson and Yamazaki, 1976; 
Fiil et al., 1977; Rauê and Cashel, 1975) characterized by a decreased rate 
of ppGpp decay and synthesis and by transient pppGpp accumulation. 
The data presented indicates that the tetracycline derivative, 5a,6-
anhydrotetracycline (Figure 9), is a potent inhibitor of several cellular 
functions. At a concentration of only 20 ng/ml, 5a,6-anhydrotetracycline 
results in a complete inhibition of RNA, protein, DNA and ppGpp accumula­
tion as well as inhibiting ppGpp decay in a spoT strain. The inhibition 
of RNA, protein and DNA synthesis, however, may be an indirect effect. 
The inhibition of syntheses of UTP and CTP by 5a,6-anhydrotetracycline is 
demonstrated. The drug was used to study and provide insight into the 
regulation of ppGpp metabolism. 
The present work was initiated by examining the effects of several 
derivatives of tetracycline on RNA accumulation to determine if variations 
between the drugs could be discerned. The following were tested; 5a,6-
anhydrotetracycline, doxycycline, oxytetracycline, chlortetracycline and 
Figure 9. The structures for tetracycline and 5a,6-anhydrotetracycllne (Blackwood 
and English, 1970) 
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dedimethylaœinotetracycline. Doxycycline inhibited RNA. accumulation at 
100 yg/ml but not at 20 Ug/ml, oxytetracycline and chlortetracycline were 
inhibitory only at concentrations in excess of 300 yg/ml and dedimethyl-
aminotetracycline failed to inhibit even at 600 Tig/ml (data not shown). 
In marked contrast 5a,6-anhydrotetracycline totally inhibited RNA accumula­
tion at concentrations above 20 yg/ml and was even inhibitory at 5 ]ig/ml 
after a lag of about 10 min as shown in Figure 10. ENA. was measured by 
incorporation as described in Materials and Methods for reasons to 
be discussed later. As shown in Figures 11 and 12, protein and DNA. levels 
as measured by ^"^C-phenylalanine and ^H-thymidine incorporation, respec­
tively, closely approximate RNA synthesis with respect to their inhibition 
in the presence of 5a,6-anhydrotetracycline. The effects of the drug are 
independent of the relA gene and of the presence or absence of charged-
tRNA. Strain 10B6 rel , which is temperature-sensitive for valyl-tRNA 
synthetase, shows inhibition of RNA. and protein synthesis by 5a,6-anhydro-
tetracycline at both the permissive and nonpermissive temperatures (Figure 
13). 
A discrepancy between the inhibition of RNA synthesis shown with 
tetracycline and that seen with 5a,6-anhydrotetracycline became apparent 
from a pulse-labeling experiment. Atherly (1974a) reported a significant 
rate of RNA synthesis in the presence of 500 yg/ml tetracycline, which was 
believed to consist of unstable species of RNA. However, pulse-labeling 
cells with ^H-uridine after treatment with 20 ]ig/ml 5a,6-anhydrotetracy­
cline failed to reveal any incorporation of label into RNA (data not 
shown). 
Figure 10. Inhibition of RM. accumulation with 5a,6-anhy<irotetracycline 
in strain CP78, RM was measured using incorporation 
as described in Materials and Methods. The assays contained 
no drug (Q), or 5 pg (•>, 10 yg (A), 20 ug (•), and 50 
yg (A) per ml 5a,6-anhydrotetracycline. The drug was added 
at 15.5 min 
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Figure 11. Inhibition of protein accumulation with 5a,6-anhydrotetra-
cycline in strain CP78. Protein accumulation was measured 
by (^H)-phenylalanine incorporation. The assays contained 
no drug (Q)» or 5 Ug (•), 10 lig (A), 20 ]lg (•), and 
50 Ug (A) per ml 5a,6-anhydrotetracycline. The drug was 
added at 15 min 
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Figure 12. Inhibition of DNA. accumulation with 5a,6-anhydrotetracycline 
in strain CP78. DNA, accumulation was measured by (^E-methyl)-
thymidine Incorporation. The assays contained no drug (O)» 
or 5 yg (H)» 10 pg (A), 20 ug (•), and 50 Vg (A) per ml 
5a,6-anhydrotetracycline. The drug was added at 20 min 
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Figure 13. The effect of 20 yg/ml of 5a,6-anhydrotetracycline on protein 
(panel A) and KNA (panel B) accumulation in strain 10B6 rel 
(valS^S), The assays were as follows: 30°C with no drug (Q); 30°C with the drug (A); 42°C with no drug 42°C 
with the drug (^) 
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The inhibition of RNA synthesis by 5a,6-anhydrotetracycline was fur­
ther investigated to determine its mechanism of action. It is unlikely 
that magnesium chelation is a factor because the molar ratio of magnesium 
in the medium to the drug at 20 yg/ml is greater than 17-to-l. 
As illustrated in Figure 14, 20 ug/ml of the drug had no effect on 
in vitro KM synthesis. At 50 yg/ml 5a,6-anhydrotetracycline there was 
about 30% inhibition of RNA synthesis by 40 min. However, the kinetics 
and amount of inhibition are not as severe as seen ^  vivo (Figure 10). 
Rifampicin prevented significant RNA synthesis in the system. It was con­
cluded that direct inhibition of RNA polymerase in vivo by 5a,6-anhydro-
tetracycline was improbable, at least at concentrations of 20 yg/ml or 
less. 
Nucleoside triphosphate levels were examined to determine if they 
were affected by the drug. As shown in Figure 15, 20 yg/ml 5a,6-anhydro-
tetracycline depressed the levels of CTP and UTP. The quantitation of the 
degree of inhibition of these nucleotides was complicated by background 
radiation on the chromatograms and variations between experiments. By 
cutting out and counting the regions on the chromatograms where the nucleo­
tides migrated we estimate CTP and UTP to be about 30% of the control 
values (i.e., with no drug added). On the other hand GTP and ATP are 
stimulated by as much as 100% by the drug. Thus, 5a,6-anhydrotetracycline 
is very likely inhibiting some step(s) in the pathway for UTP and CTP 
synthesis. The increase in GTP and ATP is most likely a secondary effect 
of the drug due to the sparing of these nucleotides in the absence of RNA 
synthesis. In this regard. Gallant and Harada (1969) reported that 
Figure 14. RNA. synthesis in vitro in the presence or absence of 5a,6-
anhydrotetracycline or rifampicin. RNA. synthesis was measured 
with no drug (Q)» 20 yg/ml (A) or 50 Pg/ml (0) 5a,6-anhy-
drotetracycline and with 10 Ug/ml rifampicin (A) 
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Figure 15. ^^POj^-labeled nucleotide pools from CP78 in the absence (A), and presence (B) 
of 20 yg/ml 5a,6-anhydrotetracycline 
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inhibiting RNA synthesis by uracil starvation results in the accumulation 
of ATP and GTP. Also, Cashel and Gallant (1968) used proflavine and 
actinomycin D to show that direct inhibition of RNA polymerase in whole 
cells and in plasmolyzed cells resulted in the accumulation of TJTP and CTP. 
Therefore, the shrinkage of UTP and CTP pools seen with 5a,6-anhydrotetra-
cycline is not an indirect effect due to the inhibition of KNA synthesis. 
The incorporation of ^H-uridine into DTP and RNA is also inhibited by the 
5a,6-anhydrotetracycline (the latter is seen in Figure 13). It may be a 
late step or steps in the synthesis of DTP and CTP that is inhibited 
because addition of 20 lig/ml cytosine and uridine to the medium failed to 
prevent an inhibition of RUA synthesis by 5a,6-anhydrotetracycline (data 
not shown). However, an inhibition of phosphorylation or uptake of uridine 
and cytosine in addition to an inhibition of the de^ novo pathway for DTP 
and CTP is probable (see Conclusions). RNA accumulation (Figure 10) 
was determined using ^^P0|^ to obtain an accurate measure of RNA levels. 
We conclude from these experiments that the inhibition of RNA synthesis 
in vivo with 5a, 6-anhydrot etracy cline is due at least in part to the de­
pression of the pyrimidine ribonucleoside triphosphates. 
It is not known whether the inhibition of protein and DNA synthesis 
(Figures 11 and 12) is a direct or indirect effect of the drug. Complete 
inhibition of RNA synthesis would presumably do both by preventing synthe­
sis of mRNA for protein synthesis and RNA primer for DNA synthesis. Evi­
dence that inhibition of protein synthesis may be a secondary effect of 
inhibiting RNA synthesis is the fact that polyuridylic acid-directed-
polyphenylalanine synthesis in a cell-free system is not inhibited by 20 
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or 50 yg/ml 5a,6-anhydrotetracycline under conditions where tetracycline 
is inhibitory (data not shown). Koschel et al. (1966) have shown that 
5a,6-anhydrotetracycline will inhibit DM synthesis in vitro but only at 
concentrations higher than those used here; 60 yg/ml of the drug gave a 
65% inhibition. 
A variety of protein synthesis inhibitors reduce ppGpp levels (for 
review see Cashel, 1975). Only with tetracycline, however, is the inhibi­
tion of ppGpp synthesis a direct effect (Kaplan e^ al., 1973). As shown 
in Figure 16, 20 yg/ml 5a,6-anhydrotetracycline totally prevented the in-
duction of ppGpp synthesis upon shifting strain 10B6 (rel , valS ) to the 
nonpermissive temperature. The drug also causes a rapid cessation of 
ppGpp synthesis when added 10 min after the shift (Figure 16). Similar 
results were obtained for pppGpp (Figure 17). 5a,6-Anhydrotetracycline 
also inhibits ppGpp synthesis in the ribosome dependent assay although a 
higher concentration of the drug was required (Figure 18). 
Sy et al. (1973) have demonstrated that stringent factor, the gene 
product of the relA allele (Block and Haseltine, 1974), can catalyze the 
synthesis of ppGpp and pppGpp in the absence of ribosomes. The assay is 
dependent on the addition of methanol and is not inhibited by thiostrepton 
which drastically reduced ppGpp synthesis using the ribosome system. 
Table 4 shows the results of ppGpp assays with K12 stringent factor. The 
synthesis of ppGpp is strongly dependent on the addition of methanol as 
expected. 5a,6-Anhydrotetracycline inhibits ppGpp synthesis in this system 
while tetracycline and oxytetracycline are even more potent inhibitors. 
Stringent factor thus appears to be one of the sites where 5a,6-
Figure 16. Inhibition of ppGpp synthesis in vivo by 5a,6-anhydrotetracycline. ppGpp 
levels were determined in strain 10B6 rel*** (valS^®) after shifting to 
42° C at 0 time with no additions (Q) or with 20 yg/ml of drug added at 
0 min (A) or at 10 min (•) 
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Figure 17. Inhibition of pppGpp synthesis vivo by 5a,6-anhydrotetracycllne. 
ppGpp levels were determined In strain 10B6 rel"*" (valS^®) after 
shifting to 42°C at 0 time with no additions (Q) or with 20 yg/ml 
of the drug added at 0 min (A) or at 10 min (Q) 
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Figure 18. Inhibition of ppGpp synthesis by 5a,6-anhydrotetracycline in 
an in vitro assay with coli ribosomes 
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Table 4. ppGpp + pppGpp synthesis by stringent factor in the presence of 
tetracycline, oxytetracycline and 5a,6-anhydrotetracycline 
Additions pmole pppGpp + ppGpp^ 
Complete (no drug) 217.5 
No methanol 12.4 
50 Ug/ml tetracycline 69.1 
100 Ug/ml tetracycline 39.3 
50 yg/ml oxytetracycline 48.4 
100 yg/ml oxytetracycline 31.5 
50 yg/ml 5a,6-anhydrotetracycline 100.2 
100 yg/ml 5a,6-anhydrotetracycline 58.0 
^Amount synthesized in 10 yl of the assay mixture. 
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anhydrotetracycline acts. The higher concentrations of the drugs required 
in the in vitro assays as compared to the ^  vivo may reflect an enhanced 
effect with functioning ribosomes. The inhibition is not due to chelation 
of magnesium as the molar ratio of the cation in the assay to the drug at 
a concentration of 100 yg/ml is 100-to-l. Also, addition of 2 mM manganese 
had no effect. 
Another effect of tetracyclines, is the inhibition of ppGpp decay in 
strains which are spoT. Two hundred-fifty ng/ml oxytetracydine was shown 
to severely inhibit ppGpp decay in strains which were spoT while having no 
effect on ppGpp decay in spoT^ strains (Stamminger and Lazzarini, 1974). 
Raue and Cashel (1975) have also demonstrated an inhibition of ppGpp decay 
in cold shocked spoT strains with 500 yg/ml tetracycline. In both of these 
reports high concentrations of the drug were required to elicit the re­
sponse. 5a,6-Anhydrotetracycline has a complex effect on ppGpp decay in a 
spoT strain (Figure 19). Twenty lig/ml of the drug inhibits ppGpp decay to 
same extent as 250 ug/ml oxytetracycline (the latter is not shown). 
However, the inhibition is reduced if the concentration is either above 
or below 20 ]ig/ml. In the case of 50 yg/ml 5a,6-anhydrotetracycline the 
rate of ppGpp decay is actually accelerated slightly. Raue and Cashel 
(1975) report that EGTA prevents the amino acid stimulation of ppGpp decay 
in a cold shocked spoT strain. The inhibition by EGTA was reversed with 
manganese. The effect of manganese on ppGpp decay in the presence of 
5a,6-anhydrotetracycline was examined. The results, shown in Figure 19, 
demonstrate a reversal of inhibition of decay by 1 mM manganese. We feel 
it unlikely that 20 lig/ml 5a,6-anhydrotetracycline inhibits decay of ppGpp 
Figure 19. The decay of ppGpp in the absence and presence of 5a,6-anhydro-
tetracycline and manganese. Strain NF161 (metB, argA, relA"^, 
spoT) was grown in the presence of in media containing 
limiting arginine. After 20 min of starvation 100 ng/ml argi-
nine was added to the culture alone (O) » or with 5 yg/ml (A) , 
20 vg/ml (Q) and 50 yg/ml 5a, 6-anhydro tetracycline and 
with 20 yg/ml 5a, 6-anhydro tetracycline plus 1 mM MhClg (gg) 
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by manganese chelation because the inhibition of decay is reversed at 
higher concentrations of the drug. Manganese may, however, stimulate 
ppGpp decay in spoT strains by acting at the same site activated by the 
aminoacyl-tKNAs (Raue and Cashel, 1975). ppGpp decay in spoT^ strains is 
not inhibited by 5a,6-anhydrotetracycline (Figure 16) nor are any of the 
other effects of the drug described here reversed by manganese. A unifying 
theory for the effects of 5a,6-anhydrotetracycline will be presented (see 
Conclusions). 
Investigating Phosphorylation as a Mechanism 
of ppGpp Action 
Reiness et al. (1975) have presented direct evidence that ppGpp 
effects the inhibition of rRNA synthesis in coli. This turning off of 
rRNA presumably occurs at the transcriptional level as opposed to an 
acceleration of rRNA decay (see Gallant and Lazzarini, 1976, for review). 
The mechanism by which this occurs has been the subject of much speculation 
and controversy (see Literature Review). Because ppGpp rises to high 
internal levels during amino acid starvation, around 4 mM (Gallant and 
Harada, 1969), it would appear that ppGpp is present in substrate amounts 
as opposed to catalytic quantities. 
The bacteriophage T7 controls host and early viral transcription by 
inducing a protein kinase that phosphorylates host RNA polymerase (Zillig 
et al., 1975). By analogy, a set of experiments were designed to test the 
possibility that ppGpp may control transcription by donating a phosphoryl 
group or other moiety to RNA polymerase. 
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[8-^H] ppGpp and [3-3'-^^P] ppGpp were prepared as described by Cashel 
(1974) as probes for detecting ppGpp moiety transfer. 
Searching for noncovalent binding of ppGpp to RNA polymerase and other 
factors 
labeled ppGpp was incubated with the supernatant of a 100,000 
X g centrifugation (SlOO) of coli extracts. The SlOO was prepared 
according to Zubay (1973). The resulting mixture was centrifuged on a 
sucrose gradient (SW 25 rotor at 24,000 rpm for 24 h). No peaks of radio­
activity could be detected in the gradient (data not shown). When the 
mixture was filtered on a membrane filter, however, significant binding 
of labeled-ppGpp could be detected. Addition of high levels of GTP re­
duced ppGpp binding by only about 20% (data not shown). These experiments 
indicate there is some noncovalent binding of ppGpp to factors in the 
SlOO. However they do not reveal which factors are responsible for the 
binding. For instance. Miller e^ al. (1973) reported binding of ppGpp to 
the elongation factor Tu. The fact that binding was not detected in the 
gradient may indicate a weak association of the factor(s) with ppGpp such 
that they dissociate during the centrifugation. These studies pointed out 
the need for a more specific assay for ppGpp binding or moiety transfer. 
If in fact moiety transfer in a covalent linkage was taking place, there 
was not enough of it to be detected by the shotgun approach outlined above. 
Precipitation and electrophoresis of RNA polymerase from cell extracts 
[3-3'-^^P] ppGpp was incubated in the cell-free extract system de­
scribed by Reiness et al. (1975) at 30'C for 3 h. The RNA. polymerase was 
precipitated by rabbit anti-RM polymerase prepared as described by Linn 
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et al. (1973). The precipitate was solubilized and electrophoresed on 
SDS-5% acrylamide dise gels. Autoradiograms prepared by drying the gels 
in a vacuum oven and exposing to x-ray film revealed no bands of label in 
the gels (data not shown). Staining duplicate gels with Coomasie Blue 
protein stain revealed that the RNA. polymerase was precipitated by the 
antibody. 
It is conceivable that ppGpp may in fact phosphorylate RNA. polymerase 
but that the conditions in the cell-free system were not optimal.. For 
instance, the specific activity of the labeled-ppGpp may have been too low 
or the enzyme responsible for the transfer somehow inactivated. Therefore 
we decided to precipitate RNA pol3?merase from extracts of cells grown in 
the presence of 
Figure 20 shows the results of an experiment involving strain NP29. 
This strain is temperature sensitive for valyl-tRNA synthetase. At the 
nonpermissive temperature abundant quantities of ppGpp accumulate. RNA 
polymerase from NP29 grown in containing media was precipitated and 
analyzed on gels as described in Materials and Methods at times after 
shifting to the nonpermissive temperature. At the left side of Figure 20 
is shown the stained gels of coli RNA polymerase (sample A) and of the 
rabbit anti-RNA polymerase preparation (sample B). The bands seen in the 
autoradiogram of Figure 20 are not coli proteins but rather rabbit 
serum proteins which are phosphorylated by the coli extracts. When 
[Y-32pj was incubated with the antibody in the absence of coli 
extract the same bands appear. Dialysis of the coli extracts failed to 
prevent phosphorylation of the serum proteins, Dansylated E, coli RNA 
Figure 20. Lack of phosphorylated RM. polymerase in JE. coli strain NP29 
during the stringent response. The stained gels are RNA 
polymerase (A); and the antibody preparation (B). The auto-
radiogram is of gels containing precipitated RNA polymerase 
at times after shifting the culture to the nonpermissive 
temperature. The bands seen are serum proteins (see text). 
The positions of the subunits of RM polymerase were deter­
mined using internal standard dansylated RM polymerase. 
Dansylation did not alter the mobility of the subunits (data 
not shown) 
Ill 
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polymerase, which fluoresces under ultraviolet radiation, was added to the 
precipitated RNA polymerase from ^^PO^-labeled cells to determine if there 
was label in the subunits of the enzyme. As shown in Figure 20 there was 
no label at the positions where the a and a subunits migrated. Labeled 
serum proteins obscured the positions where the 3* and 3 subunits migrate. 
However, there was no change in the amount of label at the position of the 
3' and 3 subunits or at the a and a subunits during or after the shift to 
42°C. These results were interpreted as evidence that ppGpp does not 
result in the phosphorylation of RNA polymerase. 
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CONCLUSIONS AMD SUMMARY 
Studies on. the Possible Existence 
of ppGpp in Eukaryotes 
As stated previously, the purpose of this work was to help elucidate 
the mechanism whereby a small molecule, namely ppGpp, regulates a pleio-
typic response and to determine if a similar control exists in higher 
organisms. It was determined that guanosine polyphosphates were not 
present in detectable levels in several eukaryotic systems with the 
possible exception of pppGpp in chloroplasts. These results, together 
with those reported in the literature, make it probable that higher organ­
isms have not retained the bacterial stringent response mechanism. Perhaps 
this conclusion should have been anticipated. The bacterial cell must 
survive as an entity. Therefore, to survive rapid and often extreme 
fluctuations in the supply of nutrients the stringent response evolved 
enabling the cell to shut down unnecessary energy-draining processes (e.g., 
ribosome synthesis). The situation with higher eukaryotic cells is quite 
different. The organism is often comprised of billions of cells. Rapid 
variations in nutrient supply are less likely due to fat deposits and 
elaborate controls on the supply and accessibility of blood sugar. In 
other words, there is an interdependence of the cells of the various 
organs and tissues on the survival of the organism. Higher eukaryotes 
may have lost this control in the process of evolving from an individual 
cell to a multicellular organism. In this regard, the recent observation 
of ppGpp in the unicellular eukaryote, cerevisiae may be significant 
(Pao et al., 1977). 
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Probing ppGpp Function and Regulation 
with 5a,6-Anhydrotetracycline 
5a,6-Aahydrotetracycline emerges from this study as a potent inhibitor 
of jE. coli metabolism. Although several cellular processes are affected 
by the drug (including RNA, protein, and DNA synthesis) direct inhibition 
was revealed for only three sites. These were; (1) UTP and CTP synthesis; 
(2) ppGpp synthesis; and (3) ppGpp decay in a spoT strain. The low con­
centration at which 5a,6-anhydrotetracycline exerts its effects, about 
20 yg/ml, indicates that the drug is not acting through an indirect route, 
e.g., magnesium chelation. The greater sensitivity of the cells to 5a,6-
anhydrotetracycline as compared to other tetracyclines tested may be due 
to its lipophilic nature (J. H. Boothe, Lederle Laboratories, Pearl River, 
N.Y., personal communication, 1977). This may allow the drug to penetrate 
the cell membrane with greater facility. 
Atherly (1974a) proposed that tetracycline acts at sites in the cell 
where ppGpp acts. The data presented herein lends support to this hypoth­
esis. The three sites of action of 5a,6-anhydrotetracycline listed above 
are all sites where ppGpp interacts. However, the drug does not interact 
at all sites where ppGpp does because ^  novo synthesis of purine nucleo­
tides are inhibited by ppGpp (Gallant et al., 1971) but not by 5a,6-anhy-
drotetracycline. 
The site of 5a,6-anhydrotetracycline inhibition in the de novo path­
way for pyrimidine ribonucleoside triphosphate synthesis is not known. 
Using whole cells, ^H-uridine incorporation into UTP and into RNA was 
inhibited by the drug. Furthermore, addition of uridine and cytosine to 
the media did not prevent the inhibition of RNA synthesis. Uridine is 
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phosphorylated to UMP by uridine kinase whereas in the ^  novo pathway 
UMP is synthesized from orotidine-5'-phosphate (0'Donovan and Neuhard, 
1970). These results may be accounted for by either of two explanations. 
First, the uptake of uridine may be inhibited in addition to a step in the 
de novo pathway for pyrimidine nucleotide synthesis. Secondly, the site 
of action of 5a,6-anhydrotetracycline may be at the level of the conversion 
of UMP to UTP and CTP. In light of a recent observation that the conver­
sion of uridine to UTP is not inhibited by 5a,6-anhydrotetracycline in 
cold-shocked permeable cells (data not shown) the first explanation is 
favored. 
In a previous publication (Atherly, 1974a), it was reported that 500 
yg/ml tetracycline did not inhibit the synthesis of nucleoside triphos­
phates. That study employed one-dimensional chromatography to resolve the 
nucleotides. I have repeated the experiment using the two-dimensional 
chromatographic technique described in Materials and Methods and find that 
500 Vg/ml tetracycline also inhibits UTP and CTP levels while stimulating 
GTP and ATP (data not shown). 
Whether the depression of UTP and CTP is partially or wholly respon­
sible for the inhibition of RNA, protein, and DNA accumulation by the drug 
is not known. The preferential inhibition of rRNA synthesis with tetra­
cycline (Atherly, 1974a) indicates that this antibiotic may be interacting 
at another site of ppGpp action, namely at the repressor of the rRNA 
opérons. However, direct inhibition of RNA polymerase by tetracyclines 
was ruled out by ^  vitro assays (Figure 14) and KtîA assays using permeable 
cells (Atherly, 1974a). 
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Tetracyclines are unique in their ability to inhibit the ribosome-
free stringent factor assay. In addition, 5a,6-anhydrotetracycline was 
shown to strongly inhibit ppGpp and pppGpp synthesis ^  vivo and ^  vitro 
in assays with ribosomes. The drug also has a complex effect on ppGpp 
decay in a spoT strain, inhibiting at 20 yg/ml but not at higher concen­
trations or in the presence of manganese. 
Raue and Cashel (1975) reported that manganese reversed the inhibition 
of ppGpp decay by EGTA in a spoT strain. They proposed a requirement for 
manganese for ppGpp decay in spoT strains. However, manganese stimulation 
capable of overriding inhibition by EGTA or tetracyclines will also account 
for the observed results. Reiner (1969) has reported a mutation in the 
polynucleotide phosphorylase gene which reduced the activity of the enzyme 
while enabling it to be stimulated by manganese, a property not seen with 
the wild type enzyme. An analogous situation may exist for ppGpp decay in 
spoT strains. 
The effect of tetracyclines on ppGpp synthesis and degradation may be 
a result of blockage of the catalytic sites for ppGpp on the respective 
enzymes. If tetracyclines are in some way analogous to ppGpp this could 
account for the inhibition of stringent factor and of the ppGpp degradative 
enzyme by these antibiotics. 
Due to its many interactions with cellular processes involved in the 
stringent response, 5a,6-anhydrotetracycline has been proven to be a 
valuable tool for probing the regulation and function of ppGpp. 
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The Role of ppGpp in the Control 
of Transcription 
Studies on the mechanism of action of ppGpp in the control of tran­
scription provide negative evidence against the existence of ppGpp moiety 
transfer or ppGpp induced phosphorylation of RNA polymerase. Two possibil­
ities for gene regulation by ppGpp which remain are direct interaction 
between ppGpp and KNA. polymerase and an indirect mechanism involving 
additional repressors and/or activator proteins. Because there is evidence 
favoring both types of controls (Cashel, 1970; Cashel et al., 1976; Block, 
1976), it is likely that both mechanisms are involved in the control of 
transcription in coli. 
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